Skip to main content
Food Science & Nutrition logoLink to Food Science & Nutrition
. 2024 Dec 13;13(1):e4641. doi: 10.1002/fsn3.4641

Nutritional, Nutraceutical, and Medicinal Potential of Cantharellus cibarius Fr.: A Comprehensive Review

Ajay Kumar 1, Reema Devi 2, Rajni Dhalaria 2, Ashwani Tapwal 1, Rachna Verma 2, Summya Rashid 3, Gehan M Elossaily 4, Khalid Ali Khan 5, Kow‐Tong Chen 6,7,, Tarun Verma 8,
PMCID: PMC11717058  PMID: 39803245

ABSTRACT

Mushrooms are considered as nutraceutical foods that can effectively prevent diseases such as cancer and other serious life‐threatening conditions include neurodegeneration, hypertension, diabetes, and hypercholesterolemia. The Cantharellus cibarius, also known as the “Golden chanterelle” or “Golden girolle,” is a significant wild edible ectomycorrhizal mushroom. It is renowned for its delicious, apricot‐like aroma and is highly valued in various culinary traditions worldwide. It is well known for its nutritional, nutraceutical, and therapeutic properties. The high nutritional value of C. cibarius is attributed to its abundant carbohydrates, proteins, β‐glucans, dietary fiber, and low‐fat content. It also contains medicinal polysaccharides (β‐glucans), proteins (lectins and selenoproteins), important fatty acids (linoleic and omega‐6), vitamins, and minerals (N, P, K, Ca, Zn, Ag, Se, etc.). The sporocarp of C. cibarius contains a diverse array of bioactive metabolites, including flavonoids, phenolics, sterols, fatty acids, organic acids, indole groups, carbohydrates, vitamins (tocopherols), amino acids, enzymes, bioelements, carotenoids, and 5ˊ‐nucleotides. C. cibarius has a wide array of biological properties, such as antioxidant, anticancer, anti‐inflammatory, antifungal, antibacterial, anthelmintic, insecticidal, antihypoxia, antihyperglycemic, wound‐healing, cytotoxic, and iron‐chelating activity. Thus, the present review gives an overview of C. cibarius, covering its chemical composition, ecological significance, postharvest preservation strategies, and potential applications in dietary supplements, nutraceuticals, and pharmaceuticals. It also dives into the etymology, taxonomy, and global distribution of the renowned “Golden Chanterelle.” Furthermore, there is a need to valorize waste materials created during production and processing, as well as to acquire a thorough understanding of the mechanisms of action of bioactive compounds in mushrooms.

Keywords: Cantharellus cibarius, culinary, ectomycorrhizal, medicinal, nutraceutical, nutritional


This review explores the nutritional, nutraceutical, and medicinal potential of Cantharellus cibarius, known as the “Golden chanterelle.” Emphasizing its rich composition of bioactive compounds and wide range of health benefits, the review also covers ecological significance, preservation strategies, and potential applications in dietary supplements, nutraceuticals, and pharmaceuticals. Additionally, it highlights the need for further research on waste valorization and the mechanisms of action of mushroom bioactive compounds.

graphic file with name FSN3-13-e4641-g001.jpg


Abbreviations

CAD $

Canadian dollar

CCP

Cantharellus crude polysaccharide

CDK

Cyclin‐dependent kinase

DPPH

2,2‐diphenyl‐1‐picrylhydrazyl

DW

Dry weight

FAOSTAT

Food and Agriculture Organization statistical

FIP

Fungal immunomodulatory proteins

FW

Fresh weight

hMNC

Human mononuclear cell

IL‐6

Interleukin‐6

iNOS

Inducible nitric oxide synthase

IU

International unit

kPa

Kilopascal

LOX

Lipoxygenase

MCF‐7

Michigan cancer foundation‐7

MFC

Minimum fungicidal concentration

MIC

Minimum inhibitory concentration

MRC‐5

Medical research council‐5

MUFA

Monounsaturated fatty acid

NFκB

Nuclear factor kappa‐light‐chain‐enhancer of activated B cells

NK

Natural killer

PAN‐C1

Pancreatic cancer cell line1

pRb

Phosphorylated retinoblastoma protein

PUFA

Polyunsaturated fatty acid

RIP

Ribosome‐inactivating proteins

ROS

Reactive oxygen species

SFA

Saturated fatty acid

TNF‐α

Tumor necrosis factor

TLR4

Toll‐like receptor 4

USD

United state dollar

USFA

Unsaturated fatty acid

1. Introduction

Fungi are the most diverse organisms on the glove containing second‐highest number of species after insects (Purvis and Hector 2000). Chytridiomycota, Zygomycota, Ascomycota, Basidiomycota, and Glomeromycota are the five primary phyla that make up the kingdom fungi (Arazo 2021). Based on their morphology and life cycles, fungi can be categorized into three main groups: single‐celled yeasts, multicellular filamentous molds, and macroscopic filamentous fungi (mushrooms) (Wakai et al. 2017). There are estimated 1.5 million species of fungi that can be grown in culture (Hawksworth 1991), but recent estimate accounts for 2.2–3.8 million of species worldwide (Hawksworth and Lücking 2017), while Wu et al. (2019) suggested an estimate of 11.7–13.2 million fungal species on the planet. The estimated record of the fungal fossil can be traced back to date as far as 900 million years with all major groups were present around 300 million years ago (Taylor, Remy, and Hass 1994).

There are estimated 150,000–160,000 different species of mushrooms, of which only around 14,000 have been identified (Chang and Wasser 2017). A macro‐fungus, or mushroom, is mainly restricted to the phylum Basidiomycota and Ascomycota of the kingdom fungi (Rathore et al. 2019; Singh and Passari 2018). Mushroom possesses distinctive sporocarp with a pileus that is supported by a stipe, thin membranous vellum that is produced during the development, and lamellae that form basidiospores (Mau, Miklus, and Beelman 1993; Shen et al. 2017) or ascospores. The sporocarp can be seen with naked eyes and grow either epigeous or hypogeous (Niazi and Ghafoor 2021). Majority of mushrooms are the members of phylum Basidiomycota, which includes about 35,000 different species (He et al. 2019). Of the 16,000 identified mushrooms, approximately 7000 exhibit varying levels of edibility (Hawksworth 2012). Primarily, there are about 3000 species of edible mushrooms, and approximately 700 have therapeutic potential (Wasser 2002; Kalac 2013; Chang and Wasser 2017; Li et al. 2021). Around 350 different types of mushrooms are consumed by people worldwide (Willis 2018). Mushrooms and fungi have more than 100 medicinal functions, and the key medicinal properties include antioxidant, antifungal, antibacterial, antiviral, antiparasitic, anticancer, antidiabetic, anti‐inflammatory, anti‐allergic, immuno‐modulating, cardiovascular protector, anticholesterolemic, hepatoprotective, and detoxification effects; they also guard against tumorigenesis processes (Lindequist, Niedermeyer, and Jülich 2005; Zhang et al. 2011; Chang and Wasser 2012; Ruthes, Smiderle, and Iacomini 2016). Mushrooms possess chemically diverse secondary metabolites that exhibit several types of biological functions which are evaluated in both conventional medicine and new targets of molecular biology (Khatun et al. 2012).

Cantharellus, Craterellus, Polyozellus, and Gomphus are the four genera that are usually referred to as “Chanterelles,” on the basis of similar appearance of their spore‐bearing surfaces without magnification (Pilz et al. 2003). On the basis of multilocus phylogenetic analyses, Cantharellus species have been characterized into seven subgenera (Buyck et al. 2014). There are currently about 300 of Cantharellus species identified worldwide (Cao et al. 2021). Cantharellus species are widely dispersed and particularly abundant in subtropical to tropical regions (Corner 1966; Buyck et al. 2013, 2014) and are being harvested since centuries from Europe, North America, Africa, and Asian forests, and on every continent, it is associated with the suitable host tree. The bicyclic carotenoid pigments and octenols attributing the characteristic odor of these mushrooms (Arpin and Fiasson 1971; Pyysalo 1976; Gill and Steglich 1987), thus due to their excellent flavor and apricot‐like aroma (Foltz, Perez, and Volk 2013).

C. cibarius Fr. is globally known as “Chanterelle” or “Golden Chanterelle” and also recognized as golden girolle. The most well‐known and widely consumed edible species in the Cantharellus genus is Cantharellus cibarius. It grows widely from June to October in India, Thailand, China, Africa, and America, and in several other European countries (Boa 2004; Eyssartier et al. 2009; Olariaga et al. 2017; Bulam, Ustun, and Peksen 2021). It is used as natural ingredient in traditional European and Asian medicines in curing liver, lungs and stomach diseases, spleen, and eyesight problems (Bulam, Ustun, and Peksen 2021). C. cibarius is known to exhibit antimicrobial (Santoyo et al. 2009; Aina et al. 2012; Novakovic et al. 2019; Chen and Xu 2024), insecticidal (Mier et al. 1996; Cieniecka‐Rosłonkiewicz et al. 2007), scavenging of lipid peroxidation (Palacios et al. 2011), antiaging, pain killer, antioxidant, and anticancer properties (Ebrahimzadeh et al. 2010; Muszyńska, Sułkowska‐Ziaja, and Ekiert 2011; Zaidman et al. 2005; Chen and Xu 2024).

The red list has classified Cantharellus and Craterellus as endangered species in many European nations (Arnolds 1995; Larsson 1997). In Netherland, the population of C. cibarius has been decreased by 60% between 1960 and 1980 (Jansen and Van Dobben 1987; Arnolds 1995). The removal of wood logs and other water‐holding substances from forests (Norvell 1992a, 1992b; Molina et al. 1993) might also result in a reduction in the formation of carpophores. Researchers have paid a lot of interest lately on the bioactive substances obtained from various mushroom species and their potential for use in dietary supplements and pharmaceuticals. This paper provides an overview of current understanding regarding chemical make‐up, ecology, postharvest preservation methods, and prospective use in dietary supplements, nutraceuticals, and pharmaceuticals in reference to C. cibarius.

1.1. Methodology

A detailed compilation of information was created from published sources, covering the scientific name, family, distribution, nutritional, nutraceutical, culinary, and preservation aspects of this mushroom species. Various key phrases were employed to search for articles in online databases such as Science Direct, PubMed, Google Scholar, and Web of Science, using terms like Cantharellus cibarius, ectomycorrhizal, nutritional, nutraceutical, medicinal, and culinary. This study analyzed a range of scientific literature, including review articles, research papers, and books published up to 2024.

2. Etymology and Taxonomy

In reference to their funnel‐like shape, the “Chanterelle” word is taken from a Greek term “kantharos,” meaning “cup,” “goblet,” or “drinking vessel” (Persson and Mossberg 1997). ″Chantarellen″ were recognized as common edible mushrooms by a Swedish naturalist Linnaeus (1747). Later he termed the golden chanterelle with the scientific name Agaricus chantarellus (Linnaeus 1755). It was Elias Fries, a Swedish scientist and botanist, who first time describes and assigned the current scientific name ″Cantharellus cibarius″ for golden chanterelle in his book Systema Mycologicum (Fries 1821), and later in 1905, the species was typified with Cantharellus cibarius Fr. (Earle 1905). Cantharellus was initially described as an artificial assembly of species with veins or folds similar to hymenophore by early authors (Fries 1821; Fries 1874; Fuckel 1870; Quélet 1888), later that broad idea was subsequently narrowed to species in the cantharelloid clade (Moncalvo et al. 2006; Buyck et al. 2014). The family Cantharellaceae was later revised by Petersen (1971a, 1971b) and Romagnesi (1995) using classical microscopic and chemical characteristics.

One of the eight major clades of homobasidiomycetes is the cantharelloid clade, having polyphyletic origin and includes the genus Cantharellus as a key member (Hibbett and Thorn 2001; Pilz et al. 2003; Binder et al. 2005; Moncalvo et al. 2006). The species in genus Cantharellus are characterized by gymnocarpic sporocarps that are fleshy, terricolous, and enduring, but not perennial (Smith and Morse 1947; Petersen 1985; Danell 1994a; Pegler, Roberts, and Spooner 1997; Cairney and Chambers 1999). Specific epithet “cibarius” is a Latin word which means “food or nutriment” (Lewis 1891). C. cibarius has a medium to big fruiting body that is generally egg‐yolk yellow in color. Gills that extend down the stalk are blunt, thick, branched, and widely spaced. At first, the cap is shallowly convex, but it quickly becomes flat, and at the center, it depresses shallowly to deeply. The margin of cap is frequently wavy and indented, and it can range from a bright yellow to an orange‐yellow that darkens when bruised, but can also fade to whitish in sunshine. Fruit body smells vaguely of dried apricots or is absent, and flavor is unremarkable. Stalk is solid, tapers downward from cap. Spore print has a light‐yellow color. Spores are smooth, ellipsoid, thin‐walled, and measure 8–11 × 4.5–5.5 μm (McKnight and McKnight 1987). Hyphae are monomitic; cystidia are absent and clamp connections are present.

3. Ecology and Distribution

C. cibarius as shown in Figure 1 is the wellspring of the majority of information about the ecology of species in the Cantharellus genus (Danell 1994a). Ecological preferences of C. cibarius estimated with Ellenberg's scales indicate that the species prefers a temperate climate, shade‐resistant, and is rarely observed in full illumination; mesophyte, as determined by the soil humidity scale and prefer acidic nitrogen‐poor soils, with neutral nitrogen‐rich soils serving as an exception (Luginina and Sorokina 2021).

FIGURE 1.

FIGURE 1

Photograph showing C. cibarius in its natural habitat.

The species of Cantharellus genus reacts to primary soil factors like pH, organic matter, and drainage (Jansen and Van Dobben 1987), as well as secondary factors, for instance, humus properties (Nantel and Neumann 1992) and nitrogen (Wallenda and Kottke 1998). C. cibarius tends to favor mostly sandy soils (Jansen and Van Dobben 1987), with low nitrogen content and a pH range of 4.0–5.5 (Jansen and Van Dobben 1987; Danell 1994a; Rangel‐Castro 2001). Besides that, other important variables have been investigated and confirmed to be crucial for the fructification of chanterelles, such as needle cover and duff depth (Bergemann and Largent 2000), moisture, vascular plants, air and soil temperature (Amaranthus and Russell 1996), and canopy coat (Pilz, Molina, and Mayo 2006). Throughout the world, the extensive host range of C. cibarius includes coniferous and broad‐leaved plants. However, certain physiological strains are specifically adapted to particular host trees. In boreal woodlands, chanterelle sporocarps first appear in mid‐July and continue throughout late October (Danell, 1994a, 1994b), and its development might differ significantly on locations and yearly basis (Egli et al. 2006). In southern taiga and subtaiga zones, the species is primarily found in pure pine forests or mixed (spruce and birch) in the tree stands of lichen, green‐moss and cowberry types, with low to medium crown densities (Luginina and Sorokina 2021). Fruit bodies of C. cibarius are generally found in the association with older trees (Danell 1994a, 1994b). Moreover, the temperature and host's growth rate figure out the golden chanterelles production in forests when the trees are between 10 and 40 years old (Okan et al. 2014).

Cantharellus is an ectomycorrhizal genus, forms mutualistic relationship with several economically valuable trees (Redhead, Norvell, and Danell 1997), and includes members of Pinaceae, Salicaceae, Betulaceae, Fagaceae, Juglandaceae, and Leguminosae (Danell 1999; Kumari, Upadhyay, and Reddy 2011; Buyck et al. 2014; Henkel et al. 2014; De Kesel et al. 2016; Ogawa et al. 2018; Cao et al. 2021; Shao et al. 2021). The genus Cantharellus includes about 23 species in North America, nine in Europe, seven in each of South America and Australia, 46 in Africa, 3 in New Zealand, and 19 in Asia (Eyssartier 2003; Tibuhwa et al. 2008; Eyssartier et al. 2009; Buyck and Hofstetter 2011; Buyck et al. 2011; Shao, Tian, and Liu 2011).

4. Nutritional Profiles

Mycophagy is a practice of eating mushrooms. The custom of collecting and eating wild edible mushrooms has a long history (Ho, Zulkifli, and Tan 2020). According to their intended application, mushrooms can be conveniently classified into the following three categories: edible (54%), wild (8%), and medicinal (38%) (Royse, Baars, and Tan 2017). A “Mushroom” could be poisonous, edible, or unpleasant because the distinction between poisonous and edible fungi is not always discernible (Hay 1887; Arora 1986). Mushrooms are excellent source of amino acids, proteins, glycogen, lipids, vitamins (Okhuoya et al. 2010), and minerals like phosphorus, magnesium, selenium, copper, and potassium (Mallikarjuna et al. 2013), fibers, phenolic compounds (Bano and Rajarathnam 1988; Lu et al. 2020), chitin, and β‐glucans (Feeney et al. 2014). High selenium content (63 μg/g DW) was reported in C. cibarius (Kolundzic et al. 2017), and selenium is an important element of rare amino acid (selenocysteine), that constitute selenoprotein. The selenoprotein plays a vital role as an antioxidant and hence reduces heart diseases and boosts immunity and cancer chemoprevention (Tinggi 2008). Selenium and copper both possess antioxidant properties that protect against damaging free radicals, therefore implicated as potential anticarcinogenic agents (Satyanarayana et al. 2006; Zuo et al. 2006).

Since the Medieval era, Chanterelles (Cantharellus spp.) have been recognized as among the most beloved edible mushrooms (Lobelius 1581; Danell 1994a). Cantharellus mushrooms are well recognized and are a preferred cuisine in various parts of the world. This mushroom is widely appreciated for its fruity, apricot‐like aroma. C. cibarius is abundant in proteins, carbohydrates, vitamins, minerals, and aromatic compounds (Bak et al. 2023; Chen and Xu 2024; Senila, Senila, and Resz 2024). High nutritional value of C. cibarius is due to its high amount of carbohydrates (31.9% DW), proteins (53.7% DW), β‐glucans, dietary fiber, and low levels of fat content (2.9% DW) (Muszyńska et al. 2016). Linoleic (654.706 mg kg−1 DW) and oleic acids (148.168 mg kg−1 DW) represent the majority of its fatty acids (Bulam, Ustun, and Peksen 2021). Egwim, Elem, and Egwuche (2011) determined proximate composition of edible wild mushrooms including C. cibarius and reported carbohydrate (18%), crude protein (26.25%), fat (9.14%), and crude fiber (13.64%). Kolundzic et al. (2017) reported α‐glucan, β‐glucan, and total glucans in dry, cooked as well as in methanolic and aqueous extract of C. cibarius. The amount of β‐glucans was 14.90–0.38 mg/g in a dried sample. It possesses the highest quantity of threonine and lysine as 8.98 and 5.74 mg g−1 DW, respectively (Beluhan and Ranogajec 2011; Muszyńska et al. 2016; Nyman et al. 2016). It contains several vitamins, notably thiamin, riboflavin, pantothenic acid, niacin, and ascorbic acid. Additionally, it also contains the vitamin B complex, vitamin A, E, D2, and minerals including calcium (973.17), potassium (67411.93), and phosphorus (5126.47), with low amount of selenium as 0.61 and 0.153 mg kg−1 DW (Costa‐Silva et al. 2011; Muszyńska et al. 2016; Bulam, Pekşen, and Ustun 2019; Bulam, Ustun, and Peksen 2019).

4.1. Carbohydrates

Mushrooms are a promising source of novel prebiotic components since they are rich in indigestible carbohydrates (Sawangwan et al. 2018; Aida et al. 2009). Moreover, there is belief that mushrooms having high mannitol content and lower glycemic index are beneficial for diabetic persons (Kozarski et al. 2015). Additionally, mushrooms also contain a high amount of complex polysaccharides. These compounds are pharmacologically crucial, and for example, lectins have antitumor and immunomodulating attributes (Wang et al. 1996; Imberty et al. 2000; Yau et al. 2015), hypotensive effects (Tam et al. 1986), and antiangiogenesis effects (Jana and Acharya 2020). The common carbohydrates of various mushrooms that display significant biological activities are fructose, glucose, xylose, mannose, fucose, rhamnose, maltose, mannitol, sucrose, and trehalose (Zaidman et al. 2005; Zhang et al. 2007; Ferreira, Barros, and Abreu 2009; Alves, Ferreira, Dias, et al. 2013; Alves, Ferreira, Froufe, et al. 2013).

In C. cibarius, carbohydrates comprise 31.9% (Muszyńska et al. 2016) and 66.07 g/100 g DW (Ouzouni et al. 2009). Total carbohydrate content in Craterellus cibarius was 12.25 and 58.67 mg g−1 in fresh and dry weight, respectively; 33.63 and 49.99 mg g−1 in fresh and dry weight of Cantharellus tubiformis, respectively; and 62.75 and 144.38 mg g−1 in fresh and dry weight of C. cibarius, respectively (Salihovic et al. 2021). Chanterelle contains trehalose (6.68 g), mannitol (8.56 g), mannose (8.56 g), and glucose (7.98 g) per 100 g dry weight (Kumari, Reddy, and Upadhyay 2011). In reference to fresh weight, Croatian C. cibarius contains 31.91 g carbohydrates, 2.9 g of lipids, 8.8 g of ash, and 118 kJ of energy (Muszyńska et al. 2016). C. cibarius harvested from Greece contain more sugar contents (66.07 g/100 g DW) as compared to croatian counterpart (Ouzouni et al. 2009; Beluhan and Ranogajec 2011). In Cantharellus spp., high carbohydrate concentration (64.24%) was observed by Ugbogu et al. (2020), approximately 54% for C. cibarius (Panchak et al. 2020), and 30.4 mg g−1DW of extract in C. cibarius (Kozarski et al. 2015). Two glucan type polysaccharides (PsCcib‐I and II) were isolated from the wild edible C. cibarius. The polysaccharide isolated from hot aqueous NaOH fraction (PsCcib‐II) exhibited a triple helical conformation (Villares et al. 2013). Polysaccharides of chanterelles like other carbohydrates (β‐glucans) of Basidiomycota species exhibited multifrontal antioxidant, anticancer, or chemoprevention activities (Jin and Lu 2011; Nowacka‐Jechalke, Olech, and Nowak 2018). They bind to free radicals, stimulate immune system or induce apoptosis, thus, prevent DNA damage, inhibit the activation and concentration of carcinogens, and restrict the development of neoplastic cells (Muszyńska et al. 2016). Three different polysaccharides, a water soluble (1–6) α‐D‐mannan and two types of β‐glucans, were isolated by Nyman et al. (2016) from C. cibarius mushroom. A unique polysaccharide (JP1) was purified by Chen et al. (2017) from the same species and found that it can facilitate the induction of peritoneal macrophages to release nitric oxide (NO), and increase the secretion of cytokines (IL‐6) in macrophage cell line (RAW264.7) of mouse. A new heteropolysaccharide (CC‐1) extracted from C. cibarius exhibited substantial in vitro antioxidant activity and immune cell proliferation effect (Zhao et al. 2018). The study revealed that CC‐1 has the potential to scavenge ABTS+ and DPPH free radicals at certain concentration levels.

4.2. Proteins and Amino Acids

Mushrooms are excellent source of proteins and play key role in both nutraceuticals and pharmaceuticals. The quantity of protein in mushrooms is nearly four times higher than that of tomatoes, six times that of oranges, and twelve times that of apples (Kakon, Choudhury, and Saha 2012; Chang 2003). One of the essential parts of Chantarelle is crude proteins. Ugbogu et al. (2020) have observed crude proteins content (13.71%–53.7%) in Cantharellus species. C. cibarius contain protein content (21.57 g/100 g) in dry mass of fruiting body (Ouzouni et al. 2009), and it was 9.3 mg g−1 DW of methanol extract (Kozarski et al. 2015).

The proteins like fungal immunomodulatory proteins (FIPs), antifungal and antimicrobial proteins (Lam and Ng 2001a, 2001b; Wong et al. 2010; Diling et al. 2017), ribonucleases (Kobayashi et al. 1992), ubiquitin‐like proteins (Lam, Ng, and Wang 2001; Zhou et al. 2017), ribosome‐inactivating proteins (RIPs) (Lam and Ng 2001a, 2001b; Wang and Ng 2001a, 2001b; Wong, Wang, and Ng 2008), lectins (Yagi et al. 1997; She, Ng, and Liu 1998; Marty‐Detraves et al. 2004), and laccases (Garzillo et al. 2001; Fukuda et al. 2001; Tinoco, Pickard, and Vazquez‐Duhalt 2001) are a few examples of mushroom proteins and these have interesting biological activities (Ng 2004; Xu et al. 2011). Several types of mushrooms contain lectins—the proteins that bind to carbohydrates. These mushroom protein “Lectins” have shown medicinal potentials including antitumor, antiviral, antifungal, antibacterial, immunomodulatory, and antiproliferative activity (Singh, Bhari, and Kaur 2010; Chatterjee, Halder, and Das 2021). The lectins found in chanterelle extracts typically agglutinate human type erythrocytes (Muszyńska et al. 2016). According to Lam, Ng, and Wang (2001), lectins and ubiquitin‐like proteins have antiproliferative effects on tumor cell lines and antimitogenic effects on spleen cells. They also have immunomodulatory and HIV‐1 RTase‐inhibitory effects (Wang et al. 1995; Wang and Ng 2001a, 2001b; Wu, Wang, and Ng 2011). A ubiquitin‐like peptide in C. cibarius possesses ribonucleolytic activity towards different polyhomoribonucleotides (Wang, Ngai, and Ng 2003).

The laccases are copper‐containing ligninolytic enzymes, and they have potential applications in biotechnology (Palmieri et al. 1993; Brenna and Bianchi 1994; Couto and Herrera 2006; Guest and Rashid 2016), like bio‐bleaching of paper pulp (Lu and Xia 2004; Camarero et al. 2004; Gutierrez et al. 2007; Camarero et al. 2007), bio‐catalysts in decolorization of synthetic recalcitrant dye (Hou et al. 2004; Camarero et al. 2005; Palmieri, Cennamo, and Sannia 2005; Michniewicz et al. 2008), detoxification or treatment of industrial effluents (Murugesan 2003; Dodor, Hwang, and Ekunwe 2004; Jaouani et al. 2005; Wu et al. 2008), and organic synthesis (Mikolasch et al. 2002; Karamyshev et al. 2003; Ncanana and Burton 2007). The mushrooms are rich source of laccase enzymes. The primary medicinal properties of laccases from basidiomycetes that have been documented so far include anticancer (Guest and Rashid 2016), antitumor, antibacterial, antioxidant, antidiabetic, and hypocholesterolemic activity (Jasim 2017). Antiproliferative activity of some mushroom proteins has been proved toward human hepatoma Hep G2 cells and T‐cell leukemia, and laccases are cytotoxic to breast cancer (MCF‐7) cells by targeting 17β‐estradiol (Xu et al. 2011; Guest and Rashid 2016). Ng and Wang (2004) isolated a homodimeric laccase from the sporocarp of C. cibarius.

Chanterelles contain high content of lysine and threonine amino acids (5.74 and 8.98 mg g−1 DW) (Beluhan and Ranogajec 2011). Cantharellus species contain glutamic acid (12.90 g), aspartic acid (7.74 g), leucine (7.56 g), and low tryptophan (0.92 g) per 100 g of protein (Ugbogu et al. 2020). Amino acid content was approximately 4.5% for C. cibarius (Panchak et al. 2020). Mushrooms are important source of a unique biomolecule, for example, ergothioneine, act as an essential antioxidant, improve health, and can be used as a food preservative, thus encouraging their use as functional foods. It is natural occurring amino acid and biologically derived from histidine (Richard‐Greenblatt et al. 2015; Rathore et al. 2019; Borodina et al. 2020). Ergothioneine was recorded 4.09 mg g−1 DW of C. cibarius (Martinez‐Medina et al. 2021). Fruiting bodies of several types of mushrooms are rich source of free amino acids. C. cibarius contains several types of L‐amino acids/mg mL−1 such as arginine (146.70), cystine (55.84), methionine (17.67), alanine (168.0), phenylalanine (72.10), lysine (65.80), valine (25.30), glycine (83.24), and leucine (65.74) (Salihovic et al. 2019). Craterellus cibarius contain alanine in higher amount, that is, 6.87 and 10.5 mg g−1 in fresh and dry, respectively. In C. cibarius, arginine present in higher amount, that is, 10.4 and 9.75 mg g−1 in fresh and dry weight, respectively (Salihovic et al. 2021).

4.3. Lipids

Mushrooms are rich in essential fatty acids (52%–87% USFA), especially linoleic acid, which the body unable to produce on its own, but required for health (Mokochinski et al. 2015; Chaturvedi et al. 2018). Polyunsaturated fatty acids (PUFA) are mostly found in edible mushrooms and enable them to significantly lower serum cholesterol (Chatterjee, Halder, and Das 2021). Majority of mushrooms contain PUFA, particularly linoleic acid, an essential omega‐6 fatty acid (Sande et al. 2019). Linoleic acid performs various physiological functions, including lowering blood pressure, triglyceride levels, cardiovascular disorders, and arthritis (Puttaraju et al. 2006; Ferreira, Barros, and Abreu 2009; Reis et al. 2012; Alves, Ferreira, Dias, et al. 2013; Alves, Ferreira, Froufe, et al. 2013). Fatty acids display remarkable antifungal and antimicrobial properties (Muszyńska et al. 2016). Edible mushrooms also contain important sterols (e.g., ergosterol) that may also be responsible for the antioxidant activity. According to research, sterols rich diet can help avoid cardiovascular problems (Barros et al. 2007; Kalac 2013). A fatty acid, that is, acetylenic acid isolated from C. cibarius, displays a significant transcriptional activity toward peroxisome proliferator–activated receptor γ (PPARγ), which controls inflammatory processes and cell growth and regulates metabolism of glucose and lipids (Muszyńska et al. 2016).

Fresh chanterelles contain ergosterol (24.7 mg), ergosta‐7‐enol (0.2 mg), and an equal amount (0.4 mg) of ergosta‐7,22‐dienol and ergosta‐5,7‐dienol (Muszyńska et al. 2016). The mushroom C. cibarius contain palmitic, palmitoleic, oleic, lauric, myristic, pentadecanoic, heptadecanoic, stearic, arachidonic, linoleic, behenic, cis‐8,11,14‐eicosatrienoic, cis‐11,14‐eicosadienoic, lignoceric, and tricosanoic acids. The major fatty acids were reported to be linoleic acid as 654.706 mg and oleic acid as of 148.168 mg (kg−1 DW); however, arachidonic acid was reported for the first time in C. cibarius (Ribeiro et al. 2009). High level of oleic acid (12.45%) has been recorded in Cantharellus species, followed by stearic acid (11.28%) and palmitic acid (8.05%) (Ugbogu et al. 2020).

The C. cibarius sporocarps contain a number of fatty acids, with 14,15‐dehydrocrepenyic acid being among the most prominent. It is found both as a free fatty acid and as a triglyceride. 14, 15‐dehydrocrepenyic acid is thought to be the precursor of cibaric acid (Pang and Sterner 1991). Linoleic acid (31.42%) reported to be a dominant component in hexane fraction of C. cibarius (Panchak et al. 2020). Ayaz et al. (2011) recorded 45.6% linoleic acid, 8.4% oleic acid, and the essential fatty acids in Chantharellus cibarius of Turkey. Kavishree et al. (2008) reported 20.8% linoleic acid and 25.9% oleic acid in Cantharellus clavatus from India. Ouzouni et al. (2009) reported that fruiting body of C. cibarius contains fat content (2.88 g) per 100 g dry fruiting body mass. Kolundzic et al. (2017) determined the various fatty acids, that is, MUFA (0.86%–45.43%) with oleic acid and cis‐vaccenic acid as principal fatty acids, followed by PUFA (0.53%–33.77%) having linoleic acid as the predominant fatty acid (0.50%–31.80%) in cyclohexane extract of C. cibarius. Along with fatty acid analysis, several types of ergosterol derivatives were identified by them in C. cibarius, that is, ergosta‐5,7,9 (Kozarski et al. 2015); 5,6‐dihydroergosterol; 22‐tetraen‐3b‐ol; ergosta‐4,6,8; ergosta‐5,7‐dien3‐ol; ergosterol; 22‐tetraen‐3‐one; and ergosterol acetate, euphorbol, and lanosterol as well. Chanterelle contains more saturated fatty acid (SFA) that accounts for 926.953 mg/kg dry matter followed by PUFA (655.176) and MUFA (148.493) (Ribeiro et al. 2009). Monounsaturated fatty acids (MUFA) and polyunsaturated fatty acids (PUFA) are more potent fungicides in comparison with saturated fatty acids (SFA). Additionally, its apricot‐like and cooked carrot‐like odor is due to aromatic C8 volatile compounds, that is, 3‐octanone, (E)‐2‐ octenol, (E)‐2‐octenal, and octanal (Aisala et al. 2019), and 1‐octen‐3‐ol that is synthesized during free linoleic acid oxidation reaction catalyzed by oxidoreductases. This reaction is intensified, particularly during drying process (Kalac 2009).

4.4. Vitamins and Minerals

Edible mushrooms are rich wellspring of nutritionally significant vitamins (group B, C, D, and E) (Vetter 1994; Mattila, Suonpää, and Piironen 2000; Mattila et al. 2001; Heleno et al. 2010; Kalaras, Beelman, and Elias 2012). The B‐vitamins that are most frequently recorded in edible mushrooms include thiamine, riboflavin, pyridoxine, nicotinic acid, pantothenic acid, folic acid, cobalamin, and nicotinamide (Assemie and Abaya 2022). In today's scenario, oxidative stress contributes to the progression of numerous chronic conditions, such as diabetes and cancer (Ceriello and Motz 2004), as well as other cardiovascular diseases (Heitzer et al. 2001). Recent research suggested that antioxidants can control autoxidation by inhibiting or preventing the free radical proliferation and thus subsequently reduce oxidative stress, boost immune function, and lengthen healthy lifespan (Tan et al. 2018). Vitamins C and E, tocopherols, and carotenoids react with free radicals, especially peroxyl radicals and singlet molecular oxygen, which is the basis of their antioxidant activity (Sies, Stahl, and Sundquist 1992). There are few overlooked antioxidant vitamins that include vitamin D, vitamin K, riboflavin, pyridoxine, and niacin which function as coenzymes to combat free radicals, and their deficiencies hasten the development of oxidative stress (Sinbad et al. 2019). The substances that are responsible for antioxidant activity also have a variety of biological effects, including the protection from malignancy, heart diseases, and various degenerative disorders (Chatterjee, Halder, and Das 2021). Vitamin E has potential to prevent DNA damage and reduce the risk of cardiovascular diseases, which is due to its antioxidant, anti‐inflammatory, and anticancer activities (Jiang 2014). Number of researchers are aware with salient functions of various vitamins like, Phytonadione (vitamin K) as neuroprotective (Li et al. 2003), riboflavin and calcitriol control lipid peroxidation and protein carbonylation (Wang et al. 2011; AlJohri, AlOkail, and Haq 2018), and vitamin B12 increase viability of retinal ganglion cells (Chan et al. 2018).

Chanterelle mushrooms have a wealth of vitamins A and E. In nature, vitamin E occurs in eight different forms: α‐, β‐, γ‐, and δ‐tocotrienol and α‐, β‐, γ‐, and δ‐tocopherol (Barros et al. 2008; Jiang 2014). Ergocalciferol, tocopherols, and carotenoids have also been reported in the chanterelle, and the tocopherol content was reported to be approximately 0.82% (Panchak et al. 2020). Fresh chanterelle is also a good source of vitamin D2 (14.2 μg/100 g FW), while dried sporocarps hold 0.12–6.3 μg g−1 of ergocalciferol after 2–6 years of storage (Muszyńska et al. 2016). C. cibarius contain high content of ergocalciferol as equivalent to those in fish. Ergocalciferol concentrations in different dried fruiting bodies varied from 0.12 to 6.30 μg g−1 (Rangel‐Castro, Staffas, and Danell 2002), and the folic acid content of C. cibarius was reported 5.07 g/100 g in C. cibarius by Egwim, Elem, and Egwuche (2011). Vitamin A level recorded the highest (16.65 IU/100 g) in quantity as compared to other vitamins (B1, B2, B3, B6, B12, and C) in Cantharellus species (Ugbogu et al. 2020). Fresh mass of C. cibarius contains high content of vitamin C (1.95 mg g−1) and low (0.52 mg g−1) in dry mass (Salihovic et al. 2021).

Mushrooms collected from natural habitats are the common constituents of nutritionally valuable minerals (Falandysz and Borovička 2013), like, Se, Cu, K, P, Mg, Mn, Na, Fe, Ca (Mattila et al. 2001), and zinc that are required for proper regulation of metabolic pathways (Das et al. 2021). Minerals from the growth media are accumulated in the sporocarps of mushrooms (Rajarathnam, Shashirekha, and Bano 1998; Kalac 2010). Attempts are being made in biofortification of cultivated mushrooms with biologically active and medicinally important minerals, like Se, Li, and Fe (da Silva et al. 2010; Hong et al. 2011; De Assuncao et al. 2012; Kaur, Kalia, and Sodhi 2017; Budzyńska et al. 2022). Moreover, selenium acts as a strong antioxidant mineral (Jayachandran et al. 2018).

Falandysz and Drewnowska (2015) provided information of elements found in C. cibarius from Poland. Similar investigation was performed by Drewnowska and Falandysz (2015) with the same species. Fruiting bodies of chanterelle investigated from all places were comparatively rich in essential elements, viz., K, P, Cu, Mg, Zn, Mn, Ca, Na, Co, and Fe. This mushroom, that is, C. cibarius, efficiently accumulates K, P, Cu, Na, Rb, Cd, Ag, and Zn from the soil. A high content of calcium was recorded in C. cibarius followed by K and P (Wang et al. 2014; Kolundzic et al. 2017). Ugbogu et al. (2020) reported highest level of Ca2+ions followed by K+ and Fe2+ ions in Cantharellus species.

Additionally, mushrooms are regarded as promising bioremediation agents for soils contaminated with heavy metals, with many edible species capable of efficiently accumulating these metals in their tissues (Drewnowska et al. 2017). The presence of chemical elements in food, both essential and harmful to humans, such as As, Cd, Hg, and Pb, raises significant concerns among consumers (Drewnowska and Falandysz 2015). C. cibarius is known to accumulate heavy metals like Cu, Cd, Hg, and Pb (Falandysz et al. 2012; Drewnowska et al. 2017; Balta et al. 2018; Uzun et al. 2023). Therefore, techniques for reducing heavy metal concentrations prior to consumption are essential. According to research, blanching fresh chanterelles can decrease cadmium (Cd) levels by approximately 11% ± 7% to 36% ± 7%, while blanching frozen mushrooms can reduce Cd content by about 40 ± 6%. Both blanching and pickling are shown to significantly lower Cd levels in C. cibarius (Drewnowska et al. 2017). When sliced fruiting bodies of Imleria badia were boiled under reflux for 15–60 min, cadmium (Cd) leaching was more effective in frozen mushrooms (58%) compared to fresh ones (36%), with boiling duration having no significant effect. For C. cibarius, simply washing the halved fruiting bodies under running tap water for about 45 s prior to cooking increased the amount of liquid released and enhanced the removal of radionuclides, specifically 137Cs and 134Cs, by approximately 30% during cooking (with vegetable oil in a pan) (Steinhauser and Steinhauser 2016).

5. Nutraceuticals and Medicinal Profile

“Nutraceuticals” term was first time coined in 1989 by Stephen De Felice (Kalra 2003). According to Daliu, Santini, and Novellino (2018), “A product could be considered as nutraceutical, if it has a positive effect on health, confirmed by clinical testing.” Nutraceuticals are dietary supplements having noteworthy health benefits and also prevent the onset of several maladies (Chatterjee, Halder, and Das 2021) by strengthening human performance (Chang and Buswell 1996; Prasad et al. 2015; Ma et al. 2018).

Medicinal mushrooms are defined as those that produce secondary metabolites and have a variety of biological purposes. Approximately 270 different kinds of mushrooms have therapeutic potential (Shamtsyan 2010), and only a small proportion of mushrooms are considered as nutraceutical mushrooms (Wu et al. 2019). Mushrooms have been used as food and even as medicine for thousands of years (Beelman, Kalaras, and Richie 2019), particularly in Asian countries (Japan, China, and Korea), as well as in some regions of Africa (Ozturk et al. 2015). These days many of them are being used against immune disorders and cancer risk as a supplementary medicine (Novak and Vetvicka 2008; Ooi 2008; Wasser 2011; Ren et al. 2012). In addition to their nutritional, delicacy, and functional qualities, mushrooms are considered as nutraceutical foods having medicinal and organoleptic properties (Ergönül et al. 2013; Phat, Moon, and Lee 2016; Rahi and Malik 2016). Based on bioactive properties of mushrooms, they have become popularized as a functional food, pharmaceuticals, and nutraceuticals (Jones and Janardhanan 2000; Lakhanpal and Rana 2005).

Mushrooms contain several types of nutraceuticals, such as lectins, lentinan, β‐glucan, proteoglycan, ganoderic acid, phenolics, triterpenoids, flavonoids, hispolon, calcaelin, laccase, ergosterol, nucleosides, and nucleotides (Patel and Goyal 2012; Ina, Kataoka, and Ando 2013; El Enshasy and Hatti‐Kaul 2013; Papoutsis et al. 2020). They also contain protocatechuic, p‐hydroxybenzoic, vanillic, syringic, gentisic, cinnamic, veratric, salicylic, p‐coumaric, gallic (Alves, Ferreira, Dias, et al. 2013; Alves, Ferreira, Froufe, et al. 2013), caffeic, and ferulic acids (Nowacka‐Jechalke, Olech, and Nowak 2018). In general, on the basis of chemical compositions and interactions with biochemical functions, mushroom nutraceuticals exhibit a variety of biological functions, which include anticarcinogenic, antitumor, anti‐inflammatory, antimycotic, anti‐obesity, antidiabetic, antibacterial, antiviral, antihypercholesterolemic, and antimutagenic (Borchers et al. 2008; Zhang et al. 2009; Valverde, Hernández‐Pérez, and Paredes‐López 2015; Reis et al. 2017).

C. cibarius is used in the treatment of boils and various types of abscesses and also acts as antihelmintic (Panchak et al. 2020). Moreover, decoction prepared from chantarelle mushrooms is employed as a food adjuvant in making functional frankfurters with high antimicrobial and antioxidant qualities as well as low sensorial alterations. Chantarelles are enriched with antioxidants and thus could be utilized in food products like cooked pork sausages to prevent chemical degradation and to enhance their shelf life (Novakovic et al. 2019; Novaković et al. 2020). C. cibarius is rich in minerals, carbohydrates, and free amino acids that are involved in maintaining immune system functional. Several biological properties like antioxidant, anti‐inflammatory, antimicrobial, antihypoxic, antihyperglycemic, wound‐healing, cytotoxicity, and iron‐chelating activity are shown by C. cibarius (Figure 2) (Vlasenko et al. 2019). The review has covered the most common medicinal properties of C. cibarius, which include antimicrobial, antimycotic, antihelminth, antihypoxic, cytotoxicity, antihyperglycemic, anticancerous, antioxidant, anti‐inflammatory, iron‐chelation, and wound‐healing properties.

FIGURE 2.

FIGURE 2

Biological activities of C. cibarius.

5.1. Bioactive Compounds and Pharmacological Properties

Bioactive substances are the molecules with therapeutic potential that can improve energy intake, lower down pro‐inflammatory states, reduce oxidative stresses, and overcome metabolic disfunctions (Siriwardhana et al. 2013), and thus ultimately promote better health. Bioactive compounds can influence metabolic reactions and exhibit antioxidant activity, inhibition of receptors, suppression or induction of enzymes, and gene expression (Carbonell‐Capella et al. 2014). There has been a growing interest in biologically active substances of mushrooms that have therapeutic or health benefits for mankind in curing and preventing various diseases (Rathee et al. 2012). The bioactives of mushrooms are polysaccharides (e.g., β‐glucans) and cell wall proteins, or phenolics, terpenes, and steroids as secondary metabolites (Sánchez 2017).

Medicinal mushrooms contain some unique polysaccharides that prevent the cancer like life‐threatening disease and have immunomodulatory property which strengthen the immune system (Ozturk et al. 2015). The polysaccharides have potential role in modern medicine, where β‐glucan regarded as a flexible metabolite confer a broad spectrum of biological functions (Patel and Goyal 2012; Chang and Wasser 2012; El Khoury et al. 2012; Finimundy et al. 2013). Polysaccharides of C. cibarius have numerous bioactivities such as antitumor, anticancer, antioxidant, immune‐modulatory, immune‐stimulatory, neuroprotective, antiproliferative, prebiotic, and chemopreventive. Moreover, its crude extracts also have antioxidant, antihyperglycemic, antihyperlipidemic, antihypertensive, antiinflammatory, antiangiogenic, antigenotoxic, antihypoxic, cardioprotective, antimicrobial, antiviral, LOX inhibition, cytotoxic, wound‐repairing, and age delaying properties (Muszyńska et al. 2016; Nasiry, Khalatbary, and Ebrahimzadeh 2017; Nowacka‐Jechalke, Olech, and Nowak 2018; Turfan et al. 2019; Badalyan and Rapior 2020; Thu et al. 2020; Uthan et al. 2021; Marathe et al. 2021).

Several studies have documented mushrooms as natural affluent sources of phenolics and flavonoids (Manzi et al. 2004; Valentao et al. 2005; Barros et al. 2008; Nowacka et al. 2014; Woldegiorgis et al. 2014; Heleno, Martins, et al. 2015; Sarikurcku et al. 2015), and these are important groups of biologically active compounds in the mushrooms (Oskoueian et al. 2011). Phenolics mainly including the phenolic acids, lignans, hydroxycinnamic acids, tannins, hydroxybenzoic acids, stilbenes, flavonoids, and oxidized polyphenols are found in mushrooms (D'Archivio et al. 2010; Thu et al. 2020). The phenolic compounds display antioxidant, antiviral, antibacterial activities, reduce inflammations, and protect from carcer (Silva et al. 2004; Soobrattee et al. 2005; Reis et al. 2011; Wang et al. 2014; Heleno, Ferreira, et al. 2015; Heleno, Barros, et al. 2015). A few studies (Reis et al. 2012; Smolskaitė, Venskutonis, and Talou 2015) have correlated the polyphenols with antioxidant activity. In mushroom extracts, phenolic compounds function as antioxidant by acting as peroxidase decomposers, metal inactivators, oxygen scavengers, or free radical inhibitors (Dziezak 1986).

The chanterelle mushrooms contain various kinds of phenolic compounds and organic acids (Valentao et al. 2005). C. cibarius contain major groups of primary as well as secondary bioactive metabolites, for instance, flavonoids, phenolic acids, sterols, fatty acids, organic acids, indole groups, carbohydrates, vitamins (tocopherols), amino acids, enzymes, bioelements, carotenoids, and 5ˊ‐nucleotides (Nyman et al. 2016; Muszyńska et al. 2016; Thu et al. 2020; Panchak et al. 2020). These bioactive components might be utilized in pharmaceuticals or nutritional adjuncts (Muszyńska et al. 2016).

Flavonoids are natural compounds with a polyphenolic structure. They play key role in cellular enzymatic functions because of their antioxidant, antimutagenic, anticarcinogenic, anti‐inflammatory (Panche, Diwan, and Chandra 2016), and cardioprotective function that generally associated with their antioxidant properties (Aaby, Hvattum, and Skrede 2004). Flavonoids are considered highly efficient free radical scavengers among several oxidizers, act against ROS and many other free radicals that are probably responsible for DNA damage and tumorigenesis (Le Marchand 2002). In addition to phenolics, mushrooms including chanterelle have been reported to contain flavonoids that scavenge free radical and ultimately block the radical reactions that occur at the time of triglyceride oxidation in the food system (Barros et al. 2008). The most susceptible cellular components that can be damaged by free radicals are lipids (by peroxidation process), proteins (by denaturation process), and nucleic acids (disturbing normal cell cycle). Protein denaturation is a major reason of inflammation and leads to the onset of rheumatoid arthritis. C. cibarius extracts show erythrocyte membrane stabilization effect and antiproteinase activity. The release of lysosomal constituents causes inflammation and damage which could be reduced by stabilizing the lysosomal membrane (Siju et al. 2015).

5.1.1. Antimicrobial and Antimycotic Activity

Mushrooms might be an alternative option for novel antimicrobial compounds. They provide several types of primary (peptides, proteins, and oxalic acid) as well as secondary metabolites including steroids, terpenes, and quinolones (Valverde, Hernández‐Pérez, and Paredes‐López 2015). C. cibarius exhibits antibacterial and antifungal attributes (Dulger, Gonuz, and Gucin 2004; Barros et al. 2008; Santoyo et al. 2009; Ramesh and Pattar 2010; Aina et al. 2012; Alves, Ferreira, Dias, et al. 2013; Alves, Ferreira, Froufe, et al. 2013) and trypanocidal attributes (Ustun, Kaiser, and Tasdemir 2011; Abedo et al. 2015). The acetone and methanol extract of C. cibarius also had antimicrobial activity (Aina et al. 2012; Kosanic, Rankovic, and Dasic 2013) and also reported for its liquid culture (Popova 2015). High cidal activity of phenolic acids has been reported against the majority of bacterial groups. Phenolic acids (2,4‐dihydroxybenzoic, vanillic, syringic acids) inhibited more methicillin‐resistant Staphylococcus aureus (MRSA) at MICs (0.5 mg/mL) than methicillin sensible Staphylococcus aureus (Alves, Ferreira, Dias, et al. 2013; Alves, Ferreira, Froufe, et al. 2013).

Mushroom could be used in prevention and treatment of Helicobacter pylori infection because of their valuable compounds (polyphenols and polysaccharides). All different extracts of C. cibarius performed dynamically at varying degree of MICs (62.5–250 μg/mL). Minimum inhibitory concentrations (4–32 μg/mL) were recorded for methanolic extract against H. pylori strains (Kolundzic et al. 2017). The decoction of C. cibarius displayed bactericidal activity at maximum concentration (20 mg/mL) toward Yersinia enterocolitica and Listeria monocytogenes . The fungistatic and fungicidal activity of decoction was significantly better against Candida albicans at MIC/MFC (10 mg/mL) (Novakovic et al. 2019).

5.1.2. Anticancerous and Cytotoxic Activity

About 660 species of higher basidiomycetes possess antitumor activity (Zaidman et al. 2005). As well‐known that edible mushrooms have numerous bioactive compounds and polysaccharides are one of the main constituents (Chen et al. 2018; Sharma, Singh, and Singh 2018). These polysaccharides have the ability of generating innate immune responses by boosting NO secretion and expression of pro‐inflammatory interleukins (IL‐1, IL‐6, IL‐10, IL‐12, and TNF‐α) in macrophages (Wang and Mazza 2002; Doyle and O'Neill 2006; Lai, Yang, and Lin 2015; Han et al. 2015; Zhang et al. 2022; Ye et al. 2020). A polysaccharide (CCP) from Craterellus cornucopioides is reported to activate the TLR4–NFκB pathway at concentration (40 μg/mL), which led to the increase in phagocytic function, expression of receptor (TLR4), production of cytokines, and protein kinases (Guo et al. 2020). Homopolymer and extremely complex heteropolymer glycans show antitumor activity (Chatterjee, Halder, and Das 2021). The phenomenal activities of polysaccharides obtained from C. cibarius are shown in Figure 3.

FIGURE 3.

FIGURE 3

Different activities of carbohydrates isolated from C. cibarius (CCP, Cantharellus crude polysaccharide; COX, cyclooxygenase; NK, natural killer cell; WCCp‐N‐b, a polysaccharide; Human A549 and LS180 cancer cell line).

The enzyme cyclooxygenase (COX) is responsible for producing the prostanoids, that is, prostaglandins, prostacyclins, and thromboxanes—that cause inflammation (Ricciotti and FitzGerald 2011). Anti‐inflammatory therapeutics might be responsible for the deactivation of two (COX‐1 and COX‐2) isoforms of COX enzymes. Interesting chemopreventive potential is present in C. cibarius, particularly in the treatment of colon cancer. This chanterelle species contains a unique monosaccharide with having the potential to inhibit the activation of COX‐1 and COX‐2 isoforms (Nowacka‐Jechalke, Olech, and Nowak 2018), but does not show any cytotoxicity toward normal human colon (CCD 841 CoTr) cells across the entire applied concentrations. A methanolic extract of C. cibarius is selectively cytotoxic to human cervix adenocarcinoma cells (HeLa line), K562 cell line, and MDA‐MB‐453 cell line as compared to normal lung cells (Kozarski et al. 2015). But it was observed that C. cibarius extracts (cyclohexane and dichloromethane) equally affect HeLa, N87 cells, and healthy MRC‐5 cells (Kolundzic et al. 2017). Cytotoxic effects of the extracts were also assessed toward primary mammalian L6 cells (Ustun, Kaiser, and Tasdemir 2011). Methanolic extracts of C. cibarius also exhibit high cytotoxic activity and induce apoptotic necrosis in A549 cells. Piceatannol an analog of resveratrol is identified from this mushroom as an active ingredient which is known for antiproliferative activity (Vasdekis et al. 2018).

Polysaccharides from medicinal mushrooms can activate macrophages, cytotoxic lymphocytes (NK cells), leukocytes (neutrophils), and induce gene expression of cytokines and interleukins (Zhao et al. 2020). Mushrooms contain a water‐soluble polysaccharide (β‐glucan) that triggers attack on tumor cells by T cells, NK cells, macrophages, and cytokines (Vetvicka et al. 2008). Branched mannans could be a new option in fighting colon cancer. Branched mannan obtained from CC2a fraction of C. cibarius enhances survival, proliferation, and anticancer property of human natural killer cells (NK92) against the human A549 and LS180 cancer cell line (Lemieszek et al. 2019; Lemieszek, Nunes, and Rzeski 2019). NF‐κB activity stimulates proliferation of tumor cells and suppression of apoptosis, initiates angiogenesis, and activates epithelial–mesenchymal transition that promotes distant metastasis (Xia, Shen, and Verma 2014). Sporocarps of C. cibarius contain active metabolites such as ergosterol, ergosterol peroxide, cerevisterol, β‐sitosterol, 7‐dehydrostigmasterol, tuberoside, glucoside, and cerebroside, which can inhibit NF‐κB activation by preventing it from moving from the cytoplasm to the nucleus. (Kim, Tay, and de Blanco 2008).

Macrophages are component of the innate immune system, carry out immunological surveillance and tumor defense. Tumor‐associated macrophages (TAMs) found in the tumor microenvironment and are segregated into two groups: M1 and M2 macrophages (Nielsen and Schmid 2017). Macrophages are one of the main target cells of some antitumor and immunomodulatory drugs. Tumor cell invasion, proliferation, and metastasis are associated with TAMs with M2‐like phenotype. As a result, they might be a suitable target for an efficient cancer immunotherapy. A new polysaccharide WCCP‐N‐b (linear α‐1,6‐galactan) has been purified from C. cibarius by Yang et al. (2019) and has the ability to switch M2‐like macrophages (tumor‐promoting) to tumor‐inhibiting M1‐like phenotype (Meng et al. 2019). This linear galactan has the ability to greatly boost phagocytosis by macrophages, NO secretion, and production of cytokines (TNF‐ α, IL‐6, and IL‐1) and also activates different signaling pathways (NF‐κB and MAPKs).

Numerous edible mushrooms have phytochemicals that are known to have antitumor properties. The viability of cancer cells in four cancer cell lines (U87 glioblastoma, A172 glioblastoma, PAN‐C1 pancreatic, and CH157‐MN meningioma) and one NIH3T3 fibroblast were dramatically reduced by high doses (1000 and 2000 μg/mL) of C. cibarius extracts (Chin et al. 2018). Such reduction in cancer cells could be credited to the occurrence of β‐glucans and phenolic compounds (Kolundzic et al. 2017), which exhibited antioxidative (Wang et al. 2014), as well as antiangiogenic activities (Kao et al. 2013). Han et al. (2013) isolated a protein‐bound polysaccharide fraction (JBP‐1), that is, water‐soluble and protein‐bound glucan from the sporocarps of C. cibarius. JBP‐1 possesses immunomodulatory potential when lymphocytes were selected to evaluate the immunological activity. This polysaccharide functions as an immunocompetent adjuvant and could be further used for clinical applications, such as treatment for cancers.

Various chronic degenerative diseases, including cancer, rheumatoid arthritis, diabetes, cardiovascular disease, and chronic inflammation are caused by genotoxins (Izquierdo‐Vega et al. 2017). Aqueous extract of C. cibarius showed antigenotoxic potential against damage induced by the alkylating carcinogenic agent (methyl methanesulfonate) in human mononuclear cells (hMNCs) (Méndez‐Espinoza et al. 2013).

Small RNAs from C. cibarius (Figure 4) have proved strong antiproliferative activity against human's LS180 and HT‐29 colon cancer cell lines (Lemieszek et al. 2019), while nontoxic effect was observed for CCD841 CoTr human colon epithelial cells. This happens due to the elevated p53 expression and p21‐mediated p53‐dependent cell cycle arrest. Ethanolic extract (80%) of C. cibarius exhibits antiproliferative activity when applied at 0.1 mg mL−1, and aqueous extract is weak immuno‐stimulatory at 1 mg mL−1 (Deo et al. 2019).

FIGURE 4.

FIGURE 4

Function of sRNA isolated from C. cibarius in cell cycle arrest in cancer tissues (CDK: Cyclin‐dependent kinase; pRb: Phosphorylated retinoblastoma protein).

5.1.3. Insecticidal Activity

Insecticidal activity of isolated glycerol 1, 2, and 1, 3‐dilinoleates and glycerol tridehydrocrepenynate from C. cibarius was examined against Musca domestica and Blatta orientalis by Daniewski et al. (2012). Ethanolic extract fraction showed that insecticidal activity occurred mostly in the nonpolar compounds found in the ethyl acetate layer. Insecticidal activity of the further isolated ethyl acetate fraction was reported lowered than that of the crude extracts. This finding may indicate a synergistic interaction of the constituents of the chanterelle (C. cibarius). Cieniecka‐Rosłonkiewicz et al. (2007) revealed high insecticidal activities of protic ionic liquid extract of C. cibarius against both Musca domestica and Blatta orientalis.

5.1.4. AntiHelminth Activity

Extract of C. cibarius is also used as an anthelmintic agent (Panchak et al. 2020). Fascioliasis originally affects livestock, but it is now known to affect humans. Ethanolic extract of C. cibarius has ovicidal and miracicidal activities against Fasciola spp. (Nwofor et al. 2018). Opisthorchiasis is a dangerous disease caused by Opisthorchis felineus (trematode) of the family Opisthorchiidae, which is common in Western Europe and Russia. There are a lot of complications associated with this disease and relatively have few effective treatments. Methanolic extract of C. cibarius dramatically reduced the population of O. felineus in mice bile ducts with increasing concentrations (10–1000 μg/mL) (Tsyganov et al. 2018), if applied on parasite larvae excyst.

5.1.5. Antioxidant Activity

Antioxidants have great importance in terms of combating oxidative stress that may cause numerous degenerative diseases (Helen et al. 2000). Phenolics are the principal compounds in mushrooms responsible for their antioxidant activity (Elmastas et al. 2007). Valentao et al. (2005) listed various phenolics and organic acids from C. cibarius. Antioxidant activity of these substances might serve as a defense against a variety of diseases (Mier et al. 1996). The potencies of phenolics to scavenge unstable molecules (free radicals), chelate metal ions, and inhibit lipoxygenase (LOX) enzyme may be responsible for their bioactivities (Decker 1997; Mallavadhani et al. 2006). Witkowska, Zujko, and Mirończuk‐Chodakowska (2011) explored most popular wild edible mushrooms including C. cibarius as rich sources of antioxidants such as total polyphenol contents. Polyphenol content in C. cibarius was found 270 mg/100 g in dry mass and 22 mg/100 g in fresh mass. DPPH radical scavenging ability was reported in EC50 values as 13.86 mg extract/mL, and chelating ability of ferrous ions was valued EC50 8.02 mg extract/mL. In the methanolic extract of C. cibarius, Kozarski et al. (2015) reported phenols (49.8 mg g−1) as the major antioxidant component followed by flavonoids (42.9 mg g−1). Tekeli, Dogan, and Uslu (2008) determined antioxidant activity of C. cibarius extract, which showed a higher potency than butylated hydroxytoluene (BHT) and butylated hydroxyanisole (BHA) in scavenging of DPPH free radical.

The carotenoid pigments have antioxidant properties which have been an accountable factor for positive effects on human health (Rao and Rao 2007). Particularly β‐carotene has shown promising results in laboratory assays and observed inverse association with cancer threat in epidemiologic studies (Barros et al. 2008). A peculiar biomolecule, that is, ergothioneine, is present in C. cibarius and has been regarded as a crucial biological antioxidant because of the way it cooperates with other antioxidants to prevent oxidative stress in mitochondria. Additionally, this amino acid enhances deactivation of singlet oxygen (Akanmu et al. 1991) and acts as a protective shield against oxidative damage of water‐soluble proteins (Paul and Snyder 2010).

The mushroom C. cibarius have the power of inhibition of lipid peroxidation reaction at 49.74 nM, which emphasizes its antioxidant potential (Egwim, Elem, and Egwuche 2011). Many studies have reported that the presence of flavonoids might be responsible for their antioxidant properties (Harborne and Williams 2000) and may be because of its antilipid peroxidation activity in some of the studied mushrooms. Based on linoleic acid autoxidation, maximum inhibition (74%) was reported for C. cibarius by Palacios et al. (2011). Higher flavonoids (40.01 mg QE g−1 of extract) and phenol content (40.97 mg GAE g−1 of extract) in n‐butanol fraction were observed in C. cibarius by Ebrahimzadeh, Safdari, and Khalili (2015). They also observed highest nitric oxide (NO) scavenging activity; higher DPPH scavenging activity (33.43%) in ethyl acetate fraction; high reducing potential in aqueous fraction; and highest Fe2+ chelating activity (86.13) in the chloroform fraction. In addition, C. cibarius fractions (CC2a, CC3) have shown antioxidant activity (Lemieszek et al. 2018).

5.1.6. Anti‐Inflammatory and Wound‐Healing Activity

The application of C. cibarius in wound treatment might be owing to its potent anti‐inflammatory and wound‐healing actions (Nasiry, Khalatbary, and Ebrahimzadeh 2017). Numerous neurodegenerative pathways have been intimately correlated with inflammatory mechanisms (Chen, Zhang, and Huang 2016). The anti‐inflammatory phytochemicals of C. cibarius may be utilized effectively in neuroprotection. Neuroprotective potential of polysaccharide fractions of C. cibarius was examined under different neurodegeneration models, including excitotoxicity, trophic, and oxidative stresses. The research revealed positive effects of C. cibarius fractions on neuron viability and neurite development under both stress and normal conditions. These both types of fractions (CC2a and CC3) efficiently counteract the detrimental effects induced by glutamatergic system activators (Lemieszek et al. 2018). Methanolic extract of C. cibarius exhibits anti‐inflammatory activity revealed by using RAW 264.7 macrophages (Moro et al. 2012). In response to LPS stimulation, the extracts induced suppression of nitric oxide (NO) and upregulate mRNA expression of iNOS and cytokines (IL‐1b and IL6). Palacios et al. (2011) detected pyrogallol in the extracts of Agaricus bisporus, C. cibarus, C. cornucopioides, and Lactarius deliciosus and suggested that it might have some anti‐inflammatory activities.

The peroxisome proliferator–activated receptors (PPARs) are members of nuclear receptor proteins that play vital role in the regulation of energy metabolism (Christofides et al. 2021), proliferation, differentiation, inflammation (Clarke et al. 1999; Clark 2002; Peters, Shah, and Gonzalez 2012), and tumorigenesis (Belfiore, Genua, and Malaguarnera 2009). A new acetylenic acid analogue (10E,14Z)‐9‐oxooctadeca‐10,14‐dien‐12‐ynoic acid was isolated from C. cibarius, which can selectively activate PPAR‐γ (Hong et al. 2012). These nuclear receptors play crucial role in development of adipocytes, regulation of inflammatory processes, in lipid and carbohydrate metabolism (Muszyńska, Sułkowska‐Ziaja, and Ekiert 2011).

6. Culinary Delicacy

Mushrooms have been a key part of the human diet since the prehistoric era. Mushrooms were even regarded as “Food of the Gods” by the Romans (Chatterjee, Halder, and Das 2021). It was believed by the Greek, that mushrooms provide strength during the battle and were considered as a health food or “Elixir of Life,” according to Chinese (Valverde, Hernández‐Pérez, and Paredes‐López 2015). Chanterelles commonly live in symbiotic association with trees of pine, spruce, hornbeam, and oak. They generally grow from the month of June to October. They are well regarded as a preferred delicacy in America, Africa, and Asia and in several European countries (Bulam, Ustun, and Peksen 2021). Wild C. cibarius mushroom has been found to have medicinal and health benefits, which may be another factor in its use as traditional delicacy (Kozarski et al. 2015). Through conventional culinary techniques (frying, cooking, and marination), the juvenile sporocarps can be consumed and preserved by drying, freezing, and other methods (Muszyńska et al. 2016; Sumic et al. 2016; Thu et al. 2020). Chantarelles are being served with chicken or fish dishes and widely used in omelettes, risotto recipes, delicious soups, and sauces as well (Kozarski et al. 2015). C. cibarius has apricot‐like, cooked carrot aromatic odor which is due to the presence of fatty aldehyde (octanal and (E)‐2‐octenal), ketone (3‐octanone), and alcoholic compounds ((E)‐2‐ octen‐1‐ol) (Aisala et al. 2019). C. cibarius contain taste modifier octadecadien‐12‐ynoic acids responsible for kokumi taste and several C18‐acetylenic acids (Mittermeier, Dunkel, and Hofmann 2018). Fons et al. (2003) identified various volatiles compounds in five Chanterelles including C. cibarius, and the major constituent was C8 derivatives, that is, 88.6%. These volatile components are widely reported for their various mushrooms like odors like, benzaldehyde (almond odor), benzyl alcohol (sweet‐spicy odor) as well as (E)‐1, 3‐Octadiene along with 2, 4‐decadienal responsible for apricot and plum flavors respectively. Politowicz et al. (2017) analyzed fresh and dried sporocarps of C. cibarius and reported 39 volatile compounds. There were three most prevalent compounds in fresh chanterelle, that is, 1‐ octen‐3‐ol, 1‐hexanol, and 2‐octen‐1‐ol, which were responsible for their peculiar aroma.

In Europe, after Penny Buns (Boletus edulis), golden chanterelle (C. cibarius) is the second most collected wild edible mushrooms as 1,88,000 t with 1 billion Euros worth per year (Lovrić et al. 2020; Lovrić et al. 2021). From prehistoric times to the present, edible wild mushrooms (EWM) have been highly coveted and demanded as important sources of daily food, traditional medicines, and commercial profit (Azeem, Hakeem, and Ali 2020). In several countries, EWM recognized as sustainable “meat of poverty” or “forest meat,” which is not originated from animal source (Dimitrijevic et al. 2018). The meaty taste in mushrooms is due to the presence of 5′‐nucleotides, particularly 5’‐GMP and C. cibarius also contains all of them with varied concentrations (Muszyńska et al. 2016). The consumption of the chanterelle alone is estimated to be between 150, 000 and 200, 000 metric tonnes per year worldwide (Kumari, Reddy, and Upadhyay 2011).

7. Commercial Harvest of Cantharellus

Wild mushrooms have been grouped under the category of nontimber forest products (NTFPs), through which food and income resources can be generated (Boa 2004; De‐Roman and Boa 2006; Devkota 2008; Liu et al. 2018). In 2017, around 10.2 million tonnes of mushrooms and truffles were produced globally; where Asia accounted for 80.5% between 2013 and 2017; Europe contributed 13.2%; Africa as 0.3%; America as 5.5%; and Oceania contributed 0.5% (FAO STAT 2019). In Europe and North America, chanterelles are particularly regarded for their culinary value. They are among the most widely consumed edible wild mushrooms due to their graceful stature, delicate flavor, and fruity aroma (Arora 1990). Chanterelles are nutritious, having about 10% proteins by weight (Pilz et al. 2003), contain higher content of vitamin A, as well as the richest source of vitamin D found in nature.

The annual global production of chanterelles is estimated by Watling (1997), to be 1.67 billion USD, and the global trade of chanterelle is expanding. The estimated world's chanterelle trade to be around 2, 00, 000 metric tonnes, accounting for annual worth of approximately $1.25 to $1.4 billion (Hall et al. 1998; Hall and Yun 2000). Although prices paid to harvesters fluctuate daily and seasonally in the Pacific Northwest. The annual average prices were reported consistent by Blatner and Alexander (1998), which were $2.95/pound in 1992, $4.00 in 1994, $3.02 in 1995, and in 1996 it was $3.06/pound. Rowe (1997) reported the price per pound in 1992 ranged from $ 1.25 to $ 8.00 over the course of a season, with an average of $2.00.

European countries like Turkey, Bulgaria, and Serbia are at the top in the production of C. cibarius mushroom (Sumic et al. 2016). Since 1970s, Cantharellus californicus has been gathered for commercial purposes. For a very long time, harvesters have recognized it as a unique species and refer to it as the “mud chanterelle.” Many chefs outside of California show least interest in C. californicus than other chanterelles because of its large size, high fibrous, and nonaromatic nature. During commercial harvesting, harvesters in California and Pacific Northwest typically receive 1 to 5 USD per pound (2 to 11 kg−1) for C. formosus as compared to USD 4 to 10 pound−1 (9 to 22 kg−1), or higher price could be obtained for mud chanterelle if selling directly to markets and restaurants (Arora and Dunham 2008). According to an estimate, between 1,50,000 and 2,00,000 t of wild chanterelles are produced per annum, with market price of over $1.7 billion (Mitchell and Hobby 2010).

Europe is the main market for wild edible mushrooms, with France and Germany having the highest demand. In 1992, harvesters from Idaho, Oregon, and Washington were paid in total USD 20,267,080 for 3,935,254 pounds of wild edible mushrooms, where harvesters were paid USD 3,664,261 for 1,135,175 pounds of chanterelle (Schlosser and Blatner 1994). In British Columbia, the total quantity of chanterelles harvested varies from 187,500 kg in bad season to 750,000 kg in good season (Wills and Lipsey 1999). The largest production region in British Columbia is Haida Gwaii. Approximately 11,500 kg of total production is estimated to be produced there in a good year, with the net worth of pickers ranging from CAD $ 2,25,000 to $ 350,000 based on a price range of $5.50 to $9.25 kg−1 (Tedder, Mitchell, and Farran 2000). According to a study by Ehlers and Hobby (2010), in northern Vancouver's Island, pickers receive prices CAD$ 2.20 to $16.50 kg−1 for fresh chanterelles. However, commercial pickers claimed to harvest 4.6–27.3 kg per day with expected daily earning of $22.50 to $135.00, whereas some pickers claimed the collection of 45 kg per day, which at the best price bring the earnings of $ 750. The wild mushroom industry as a whole is governed by the level of variation in harvest amounts and prices paid.

8. Cultivation Practices

Mushroom cultivation could be an alternative strategy for the conservation of certain important and endangered plant species, wherein dependence on wild resources can be reduced for nutraceuticals and phyto‐chemicals for drug preparation. Over the past ten years, the production of mushrooms and truffles has climbed from 6.90 to 10.24 million metric tonnes (Ho, Zulkifli, and Tan 2020). In next few years, the annual value of the worldwide mushroom market anticipated to be surpassing US 50 billion dollars. An approximate 0.13 million mushrooms were produced in India between 2010 and 2017, representing an average and annual increase of 4.3% growth rate (Raman et al. 2018). It is predicted that by 2023, the value of the edible mushroom industry might reach USD 62.19 billion (Research and Markets 2021). Although there are other types of mushrooms, including mycorrhizal, saprophytic, and parasitic types, but usually saprophytic are selected for artificial cultivation (Stamets 2000). Around the world, 200 different types of mushrooms are consumed as superfoods (Kalac 2013), and only three edible mushroom species—Agaricus bisporus, Pleurotus ostreatus, and Volvariella volvacea—are generally grown, out of the 33 species that are currently being cultivated worldwide (Erbiai et al. 2021). More than 30‐fold production of cultivated edible mushrooms has been achieved, and per capita consumption has increased 4.7‐fold globally since 1978 (Royse, Baars, and Tan 2017; Beelman, Kalaras, and Richie 2019).

The first functional committee for mushroom cultivation was established in 1894 at the “Mushroom capital of the world,” that is, Pennsylvania (Beyer 2003). Mushroom requires special conditions for their growth and production, like low temperature, consistent humidity, light exposure, good aeration, and appropriate substrate composition (Wani, Bodha, and Wani 2012; Hou et al. 2017). The first success in commercially production of mushroom was achieved by a Frenchman in 1978, who cultured Agaricus bisporus underground in quarries nearby Paris (Niazi and Ghafoor 2021).

In 1996, for the first time, Danell achieved sporocarp production of C. cibarius under greenhouse condition. Commercial production of chanterelles in the glasshouse condition is quite difficult, but seedlings inoculated with selected mycelia may allow commercial production. Danell planted inoculated chanterelle ectomycorrhizal seedlings into pots in a greenhouse. After several months, when seedlings acquired 16 months of age and height of 0.5 m, he reported abundant chanterelle ectomycorrhizae and fruiting bodies from the drainage holes of the pots (Danell and Camacho 1997).

There are orchards for the production of black truffles (Giovannetti et al. 1994; Chevalier and Frochot 1997). A chanterelle orchard of 225 m2 can be established by planting 100 seedlings in a square at a distance of 1.5 m from each other. In Scottish forests, Slee (1991) reported a production of 50 kg C. cibarius ha−1 year−1, while in southern Sweden, an irrigated field plot (15 × 35 m) yielded a total of 17 kg FW of C. cibarius in 1992 (Danell 1994a). In 1994, Danell developed a rapid technique for the large‐scale production of chanterelles. His technique was totally based on methods of McLaughlin (1970) and Jentschke, Godbold, and Hütterman (1991). He inoculated the seedlings of Pinus sylvestris and Picea abies with C. cibarius hyphal suspension and achieved ECM formation in 8 weeks. Several sporocarps and primordia of C. cibarius were observed with 16‐month‐old Pinus sylvestris seedlings in pots.

9. Preservation and Processing Methods

Shelf life and postharvest quality of edible mushrooms could be improved by developing durable techniques whether for short‐ or long‐term preservation. There are several such preservation techniques that are lately being used include, physical, chemical, and thermal methods (Bulam, Ustun, and Peksen 2021). The edible mushrooms can get altered chemically during preservation and thus adversely affect their nutritional contents, organoleptic and bioactive qualities, and commercial importance (Xue et al. 2017; Thakur 2018; Marcal et al. 2021). The chanterelles, preserved in vinegar and olive oil, were observed to have a significant decrease in the quantity and quality of the bioactive compounds like phenolics and organic acids (Valentao et al. 2005). Additionally, it is to be remembering that deep‐freezing is a common practice for enhancing storage stability and enables year‐round mushroom consumption without seasonal constraints (Manzi et al. 2004).

Postharvest processing techniques are little explored for chanterelle mushrooms. The consumption of fruiting bodies of C. cibarius is safe and it can be taken as fresh, dried, frozen or in pickled forms. As compared to fresh, frozen, or canned mushrooms, the shelf life of dried mushrooms is much longer. To preserve the quality of the raw material, drying can be done using the vacuum drying process at lower temperatures and low oxygen level. Vacuum‐drying is an excellent method for materials that can alter or be damaged by the impact of high temperatures. The vacuum pressure of 10 kPa and 50°C temperature is ideal for reducing water activity, maximizing the total phenolic content and the ability of vacuum‐dried chanterelle mushrooms to rehydrate (Sumic et al. 2013, 2016).

Blanching assists in food preservation techniques by reducing the numbers of contaminating microorganisms on their surfaces (Fellows 2017). Blanching of fresh sliced C. cibarius using gently boiling potable water/distilled water or with mineral/deionized water for 5–15 min caused 15% leaching of mercury (Hg), while 35% for sliced and deep‐freezed fruiting bodies. Total leaching rate (i.e., 15 to 37%) of Hg was reported for fresh pickled C. cibarius and it was between 37% and 39% when deep‐frozen fruiting bodies were processed (Falandysz and Drewnowska 2017). Similarly, blanching fresh chanterelles reduces the amount of cadmium by 11%–36%, whereas approx. 40% for deep‐freezed mushrooms. Blanching the double picked chanterelles resulted in extra loss of Cd (37%–71%). When chanterelle sporocarps were blanched and then further pickled, the overall Cd leaching rate was between 77% and 91%. The blanching and pickling greatly reduce the amount of Cd in C. cibarius (Drewnowska et al. 2017).

In C. cibarius samples, convective predrying and vacuum microwave finish drying (CPD‐VMFD) at 70°C led to an increased content (136 g 100 g−1 DW) of volatile chemicals, but neither essential amino acids nor nonessential amino acids were observed to be altered (Politowicz et al. 2017). However, drying of mushroom slices (5–7 mm) in a tunnel dryer at 70°C for 4–5 h resulted in lower content of vitamin C and total anthocyanins, which might be due to the destruction by drying (Salihovic et al. 2021). In addition, the methods like lyophilization (at −40°C) and sun‐drying (25 ± 2°C) are more advantageous in increasing the quantities of bio‐elements (Zn, Cu, Fe, and Mg) in edible mushrooms than drying in a dryer (Kala et al. 2021).

Modified atmosphere packaging (MAP) method considerably reduces decay and weight loss of C. cibarius (Ozturk, Havsut, and Yıldız 2021). As storage period passage, the significant increase was reported in total phenolics, proteins, vitamin C, ash, and dry matter as well as in antioxidant activity. Preservation and processing of mushrooms with certain bacteria is also a unique method for maintaining quality and long‐term storage. Jabłonska‐Rys et al. (2016) performed lactic acid fermentation of C. cibarius with Lactobacillus plantarum strain and reported that this bacterium can effectively lower pH and enhance gallic and ferulic acids contents in fermented mushrooms.

Thermal processing also increased the release of bioelements like zinc (Muszyńska et al. 2016), Mg, Zn, Fe, and Cu from C. cibarius into artificial digestive juices (Kala et al. 2017, 2019, 2021).

10. Conclusion and Future Prospects

The review emphasizes the significance of C. cibarius as nutritional, nutraceutical and medicinal benefits on the health of consumers. In this review, conventional as well as novel preservation and processing techniques are discussed along with cultivation techniques. As we know, mushrooms have opened an outdoor in our daily diet schedule because of high nutritional, nutraceutical, and medicinal values. In addition, mushrooms have been regarded as nutraceutical foods that are effective in preventing diseases like cancer and other severe life‐threatening disorders like neurodegeneration, hypertension, diabetes, and hypercholesterolemia. Future study should be concentrated on the discovery of new effective drugs for the well‐being of mankind. There should be a technique for recovering some essential compounds from waste generated during production and processing which could be valorized by both food and pharmaceutical industries. Finally, the mechanisms of action of bioactive compounds found in mushrooms should be studied at cellular level.

Author Contributions

Ajay Kumar: conceptualization (equal), visualization (lead), writing – original draft (equal), writing – review and editing (equal). Reema Devi: formal analysis (equal). Rajni Dhalaria: data curation (equal), writing – review and editing (equal). Ashwani Tapwal: data curation (equal), writing – review and editing (equal). Rachna Verma: data curation (equal), writing – review and editing (equal). Summya Rashid: data curation (equal), writing – review and editing (supporting). Gehan M. Elossaily: data curation (equal), writing – review and editing (supporting). Khalid Ali Khan: data curation (equal), writing – review and editing (supporting). Kow‐Tong Chen: data curation (supporting), writing – review and editing (equal). Tarun Verma: data curation (equal), supervision (equal), writing – review and editing (equal).

Conflicts of Interest

The authors declare no conflicts of interest.

Acknowledgments

Authors are thankful to the director of ICFRE—Himalayan Forest Research Institute, Shimla for the research encouragement and motivation. The authors extend their appreciation to the Deanship of Scientific Research at King Khalid University Saudi Arabia for funding this work through Large Groups Project under grant number RGP2/271/45. This study is supported via funding from Prince sattam bin Abdulaziz University project number (PSAU/2024/R/1445). Gehan M. Elossaily would like to thank AlMaarefa University, Riyadh, Saudi Arabia, for supporting this study. This study was supported by a grant (No. RD‐11302) from the Tainan Municipal Hospital (managed by Show Chwan Medical Care Corporation), Tainan, Taiwan.

Contributor Information

Kow‐Tong Chen, Email: ktchen@mail.ncku.edu.tw.

Tarun Verma, Email: tarunverma@bhu.ac.in.

Data Availability Statement

The data generated or analyzed that support the findings of this study are available and included in this published article.

References

  1. Aaby, K. , Hvattum E., and Skrede G.. 2004. “Analysis of Flavonoids and Other Phenolic Compounds Using High‐Performance Liquid Chromatography With Coulometric Array Detection: Relationship to Antioxidant Activity.” Journal of Agricultural and Food Chemistry 52: 4595–4603. 10.1021/jf0352879. [DOI] [PubMed] [Google Scholar]
  2. Abedo, A. J. , Shettima F., Abdullahi R., et al. 2015. “Anti Trypanosomal Activity of Cantharellus cibarius on Trypanosoma brucei .” IOSR Journal of Pharmacy and Biological Sciences 10: 41–45. 10.9790/3008-10514145. [DOI] [Google Scholar]
  3. Aida, F. M. N. A. , Shuhaimi M., Yazid M., and Maaruf A. G.. 2009. “Mushroom as a Potential Source of Prebiotics: A Review.” Trends in Food Science and Technology 20: 567–575. 10.1016/j.tifs.2009.07.007. [DOI] [Google Scholar]
  4. Aina, D. A. , Jonathan S. G., Olawuyi O. J., Ojelabi D. O., and Durowoju B. M.. 2012. “Antioxidant, Antimicrobial and Phytochemical Properties of Alcoholic Extracts of Cantharellus cibarius—A Nigerian Mushroom.” New York Science Journal 5: 114–120. [Google Scholar]
  5. Aisala, H. , Sola J., Hopia A., Linderborg K. M., and Sandell M.. 2019. “Odor‐Contributing Volatile Compounds of Wild Edible Nordic Mushrooms Analyzed With HS–SPME–GC–MS and HS–SPME–GC–O/FID.” Food Chemistry 15: 566–578. 10.1016/j.foodchem.2019.01.053. [DOI] [PubMed] [Google Scholar]
  6. Akanmu, D. , Cecchini R., Aruoma O. I., and Halliwell B.. 1991. “The Antioxidant Action of Ergothioneine.” Archives of Biochemistry and Biophysics 288: 10–16. 10.1016/0003-9861(91)90158-f. [DOI] [PubMed] [Google Scholar]
  7. AlJohri, R. , AlOkail M., and Haq S. H.. 2018. “Neuroprotective Role of Vitamin D in Primary Neuronal Cortical Culture.” eNeurologicalSci 14: 43–48. 10.1016/j.ensci.2018.12.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Alves, M. , Ferreira I., Dias J., Teixeira V., Martins A., and Pintado M. A.. 2013. “Review on Antifungal Activity of Mushroom (Basidiomycetes) Extracts and Isolated Compounds.” Current Topics in Medicinal Chemistry 13: 2648–2659. 10.2174/15680266113136660191. [DOI] [PubMed] [Google Scholar]
  9. Alves, M. J. , Ferreira I. C. F. R., Froufe H. J. C., Abreu R. M. V., Martins A., and Pintado M.. 2013. “Antimicrobial Activity of Phenolic Compounds Identified in Wild Mushrooms, SAR Analysis and Docking Studies.” Journal of Applied Microbiology 115: 346–357. 10.1111/jam.12196. [DOI] [PubMed] [Google Scholar]
  10. Amaranthus, M. , and Russell K.. 1996. “Effect of Environmental Factors and Timber and Mushroom Harvest on Cantharellus Production on the Olympic Peninsula, Washington State.” In Managing Forest Ecosystems to Conserve Fungus Diversity and Sustain Wild Mushroom Harvests, edited by Pilz D. and Molina R., 1–104. USA: DIANE Publishing. 10.2737/PNW-GTR-371. [DOI] [Google Scholar]
  11. Arazo, T. 2021. “CRISPR‐Based Pathogenic Fungal Genome Editing for Control of Infection and Disease.” In Progress in Molecular Biology and Translational Science, edited by Singh V., 161–196. Amsterdam, Netherlands: Elsevier, Academic Press. 10.1016/bs.pmbts.2020.12.016. [DOI] [PubMed] [Google Scholar]
  12. Arnolds, E. J. M. 1995. “Conservation and Management of Natural Populations of Edible Fungi.” Canadian Journal of Botany 73: 987–998. 10.1139/b95-349. [DOI] [Google Scholar]
  13. Arora, D. 1986. Mushrooms Demystified. Berkeley, California: Ten Speed Press. [Google Scholar]
  14. Arora, D. 1990. All That the Rain Promises and More: A Hip Pocket Guide to Western Mushrooms. Berkeley, California: Ten Speed Press. [Google Scholar]
  15. Arora, D. , and Dunham S. M.. 2008. “A New, Commercially Valuable Chanterelle Species, Cantharellus californicus sp. nov., Associated With Live Oak in California, USA.” Economic Botany 62: 376–391. 10.1007/s12231-008-9042-7. [DOI] [Google Scholar]
  16. Arpin, N. , and Fiasson J. L.. 1971. “The Pigments of Basidiomycetes: Their Chemotaxonomic Interest.” In Evolution in the Higher Basidiomycetes, edited by Petersen R. H., 63–99. Knoxville, TN: University of Tennessee Press. [Google Scholar]
  17. Assemie, A. , and Abaya G.. 2022. “The Effect of Edible Mushroom on Health and Their Biochemistry.” International Journal of Microbiology 2022: 1–7. 10.1155/2022/8744788. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Ayaz, F. A. , Chuang L. T., Torun H., et al. 2011. “Fatty Acid and Amino Acid Compositions of Selected Wild‐Edible Mushrooms Consumed in Turkey.” International Journal of Food Sciences and Nutrition 62: 328–335. 10.3109/09637486.2010.533160. [DOI] [PubMed] [Google Scholar]
  19. Azeem, U. , Hakeem K. R., and Ali M.. 2020. “Commercialization and Conservation.” In Fungi for Human Health, 97–106. Switzerland: Springer Cham. 10.1007/978-3-030-58756-7_8. [DOI] [Google Scholar]
  20. Badalyan, S. M. , and Rapior S.. 2020. “Perspectives of Biomedical Application of Macrofungi.” Current Trends in Biomedical Engineering & Biosciences 19: 1–8. 10.19080/CTBEB.2020.19.556024. [DOI] [Google Scholar]
  21. Bak, K. H. , Bauer S., Rattner J., Wagner M., and Ludewig M.. 2023. “Nutritional Properties, Microbial and Sensory Quality, and Formation of Biogenic Amines in Wild‐Grown Mushrooms (Cantharellus cibarius & Boletus edulis) From Austrian Local Markets.” Food Chemistry Advances 2: 100193. [Google Scholar]
  22. Balta, I. , Mireșan V., Răducu C., et al. 2018. “The Physico‐Chemical Composition and the Level of Metals From (Buletus Edulis) and (Cantharellus Cibarius) From the Vatra Dornei Area.” ProEnvironment Promediu 11, no. 36: 241–248. [Google Scholar]
  23. Bano, Z. , and Rajarathnam S.. 1988. “Pleurotus Mushrooms. Part II. Chemical Composition, Nutritional Value, Post‐Harvest Physiology, Preservation and Role as Human Food.” Food Science & Nutrition 27: 86–158. 10.1080/10408398809527480. [DOI] [PubMed] [Google Scholar]
  24. Barros, L. , Calhelha R. C., Vaz J. A., Ferreira I. C. F. R., Baptista P., and Estevinho L. M.. 2007. “Antimicrobial Activity and Bioactive Compounds of Portuguese Wild Edible Mushrooms Methanolic Extracts.” European Food Research and Technology 225: 151–156. 10.1007/s00217-006-0394-x. [DOI] [Google Scholar]
  25. Barros, L. , Venturini B. A., Baptista P., Estevinho L. M., and Ferreira I. C. F. R.. 2008. “Chemical Composition and Biological Properties of Portuguese Wild Mushrooms: A Comprehensive Study.” Journal of Agricultural and Food Chemistry 56: 3856–3862. 10.1021/jf8003114. [DOI] [PubMed] [Google Scholar]
  26. Beelman, R. B. , Kalaras M. D., and Richie J. P.. 2019. “Micronutrients and Bioactive Compounds in Mushrooms: A Recipe for Healthy Aging?” Nutrition Today 54: 16–22. 10.1097/NT.0000000000000315. [DOI] [Google Scholar]
  27. Belfiore, A. , Genua M., and Malaguarnera R.. 2009. “PPAR‐Gamma Agonists and Their Effects on IGF‐I Receptor Signaling: Implications for Cancer.” PPAR Research 2009: 1–18. 10.1155/2009/830501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Beluhan, S. , and Ranogajec A.. 2011. “Chemical Composition and Non‐Volatile Components of Croatian Wild Edible Mushrooms.” Food Chemistry 124: 1076–1082. 10.1016/j.foodchem.2010.07.081. [DOI] [Google Scholar]
  29. Bergemann, S. E. , and Largent D. L.. 2000. “The Site Specific Variables That Correlate With the Distribution of the Pacific Golden Chanterelle, Cantharellus formosus .” Forest Ecology and Management 130: 99–107. 10.1016/S0378-1127(99)00177-2. [DOI] [Google Scholar]
  30. Beyer, D. M. 2003. Basic Procedures for Agaricus Mushroom Growing. Cheste: Penn State College of Agricultural Sciences Research, Extension, and Resident Education Programs. [Google Scholar]
  31. Binder, M. , Hibbett D. S., Larsson K. H., Langer E., and Langer G.. 2005. “The Phylogenetic Distribution of Resupinate Forms Across the Major Clades of Mushroom‐Forming Fungi (Homobasidiomycetes).” Systematics and Biodiversity 3: 113–157. 10.1017/S1477200005001623. [DOI] [Google Scholar]
  32. Blatner, K. A. , and Alexander S.. 1998. “Recent Price Trends for Non‐timber Forest Products in the Pacific Northwest.” Forest Products Journal 48: 28–34. [Google Scholar]
  33. Boa, E. 2004. Wild Edible Fungi—A Global Overview of Their Use and Importance to People. Food and Agriculture Organization of the United Nations, 1–147. Rome: Food & Agriculture Org. [Google Scholar]
  34. Borchers, A. T. , Krishnamurthy A., Keen C. L., Meyers F. J., and Gershwin M. E.. 2008. “The Immunobiology of Mushrooms.” Experimental Biology and Medicine 233: 259–276. 10.3181/0708-MR-227. [DOI] [PubMed] [Google Scholar]
  35. Borodina, I. , Kenny L. C., McCarthy C. M., et al. 2020. “The Biology of Ergothioneine, an Antioxidant Nutraceutical.” Nutrition Research Reviews 33: 190–217. 10.1017/S0954422419000301. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Brenna, O. , and Bianchi E.. 1994. “Immobilized Laccase for Phenolic Removal in Must and Wine.” Biotechnology Letters 16: 35–40. 10.1007/BF01022620. [DOI] [Google Scholar]
  37. Budzyńska, S. , Siwulski M., Gąsecka M., et al. 2022. “Biofortification of Three Cultivated Mushroom Species With Three Iron Salts‐Potential for a New Iron‐Rich Superfood.” Molecules 27: 1–21. 10.3390/molecules27072328. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Bulam, S. , Pekşen A., and Ustun N. Ş.. 2019. “Yenebilir ve tıbbi mantarların gıda ürünlerinde kullanım potansiyeli.” Mantar Dergisi 10: 137–151. 10.30708/mantar.644367. [DOI] [Google Scholar]
  39. Bulam, S. , Ustun N. S., and Peksen A.. 2019. “Yenebilir doğa mantarlarının bazı fiziksel ve fizikokimyasal özellikleri ile mineral madde içeriklerinin belirlenmesi.” Mantar Dergisi 10: 193–203. 10.30708/mantar/638995. [DOI] [Google Scholar]
  40. Bulam, S. , Ustun N. S., and Peksen A.. 2021. “Effects of Different Processing Methods on Nutrients, Bioactive Compounds, and Biological Activities of Chanterelle Mushroom (Cantharellus cibarius): A Review.” European Food Science and Engineering 2: 52–58. [Google Scholar]
  41. Buyck, B. , Cruaud C., Couloux A., and Hofstetter V.. 2011. “ Cantharellus texensis sp. Nov. From Texas, a Southern Look Alike of C. cinnabarinus Revealed by Tef‐1 Sequence Data.” Mycologia 103: 1037–1046. 10.3852/10-261. [DOI] [PubMed] [Google Scholar]
  42. Buyck, B. , and Hofstetter V.. 2011. “The Contribution of Tef‐1 Sequences to Species Delimitation in the Cantharellus cibarius Complex in Southeastern USA.” Fungal Diversity 49: 35–46. 10.1007/s13225-011-0095-z. [DOI] [Google Scholar]
  43. Buyck, B. , Kauff F., Cruaud C., and Hofstetter V.. 2013. “Molecular Evidence for Novel Cantharellus (Cantharellales, Basidiomycota) From Tropical African Miombo Woodland and a Key to all Tropical African Chanterelles.” Fungal Diversity 58: 281–298. 10.1007/s13225-012-0215-4. [DOI] [Google Scholar]
  44. Buyck, B. , Kauff F., Eyssartier G., Couloux A., and Hofstetter V.. 2014. “A Multilocus Phylogeny for Worldwide Cantharellus (Cantharellales, Agaricomycetidae).” Fungal Diversity 64: 101–121. 10.1007/s13225-013-0272-3. [DOI] [Google Scholar]
  45. Cairney, J. W. G. , and Chambers S. M.. 1999. “Ectomycorrhizal Fungi Key Genera in Profile (Chapter 10).” In Cantharellus. Berlin, Heidelberg: Springer. 10.1007/978-3-662-06827-4_10. [DOI] [Google Scholar]
  46. Camarero, S. , Garcia O., Vidal T., et al. 2004. “Efficient Bleaching of Non‐wood High‐Quality Paper Pulp Using Laccase‐Mediator System.” Enzyme and Microbial Technology 35: 113–120. 10.1016/j.enzmictec.2003.10.019. [DOI] [Google Scholar]
  47. Camarero, S. , Ibarra D., Martinez A. T., Romero J., Gutierrez A., and DelRio J. C.. 2007. “Paper Pulp Delignification Using Laccase and Natural Mediators.” Enzyme and Microbial Technology 40: 1264–1271. 10.1016/j.enzmictec.2006.09.016. [DOI] [Google Scholar]
  48. Camarero, S. , Ibarra D., Martinez M. J., and Martinez A. T.. 2005. “Lignin‐Derived Compounds as Efficient Laccase Mediators for Decolourization of Different Types of Recalcitrant Dyes.” Applied and Environmental Microbiology 71: 1775–1784. 10.1128/AEM.71.4.1775-1784.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Cao, T. , Hu Y. P., Yu J. R., Wei T. Z., and Yuan H. S.. 2021. “A Phylogenetic Overview of the Hydnaceae (Cantharellales, Basidiomycota) With New Taxa From China.” Studies in Mycology 99: 1–62. 10.1016/j.simyco.2021.100121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Carbonell‐Capella, J. M. , Buniowska M., Barba F. J., Esteve M. J., and Frígola A.. 2014. “Analytical Methods for Determining Bioavailability and Bioaccessibility of Bioactive Compounds From Fruits and Vegetables: A Review.” Comprehensive Reviews in Food Science and Food Safety 13: 155–171. 10.1111/1541-4337.12049. [DOI] [PubMed] [Google Scholar]
  51. Ceriello, A. , and Motz E.. 2004. “Is Oxidative Stress the Pathogenic Mechanism Underlying Insulin Resistance, Diabetes, and Cardiovascular Disease? The Common Soil Hypothesis Revisited.” Arteriosclerosis, Thrombosis, and Vascular Biology 24: 816–823. 10.1161/01.ATV.0000122852.22604.78. [DOI] [PubMed] [Google Scholar]
  52. Chan, W. , Almasieh M., Catrinescu M. M., and Levin L. A.. 2018. “Cobalamin‐Associated Superoxide Scavenging in Neuronal Cells Is a Potential Mechanism for Vitamin B12–Deprivation Optic Neuropathy.” American Journal of Pathology 188: 160–172. 10.1016/j.ajpath.2017.08.032. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Chang, S. T. 2003. “Mushroom Production.” Biotechnology 7: 1–7. [Google Scholar]
  54. Chang, S. T. , and Buswell J. A.. 1996. “Mushroom Nutraceuticals.” World Journal of Microbiology and Biotechnology 12: 473–476. 10.1007/BF00419460. [DOI] [PubMed] [Google Scholar]
  55. Chang, S. T. , and Wasser S. P.. 2012. “The Role of Culinary‐Medicinal Mushrooms on Human Welfare With a Pyramid Model for Human Health.” International Journal of Medicinal Mushrooms 14: 95–134. 10.1615/IntJMedMushr.v14.i2.10. [DOI] [PubMed] [Google Scholar]
  56. Chang, S. T. , and Wasser S. P.. 2017. The Cultivation and Environmental Impact of Mushrooms. New York: Oxford University Press. [Google Scholar]
  57. Chatterjee, D. , Halder D., and Das S.. 2021. “Varieties of Mushrooms and Their Nutraceutical Importance: A Systematic Review.” Journal of Clinical and Diagnostic Research 15: OE01–OE06. 10.7860/JCDR/2021/47240.14660. [DOI] [Google Scholar]
  58. Chaturvedi, V. K. , Agarwal S., Gupta K. K., Ramteke P. W., and Singh M. P.. 2018. “Medicinal Mushroom: Boon for Therapeutic Applications.” 3Biotech 8: 1–20. 10.1007/s13205-018-1358-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Chen, L. , Peng X., Lv J., Liao S., Ou S., and Shen Y.. 2017. “Purification and Structural Characterization of a Novel Water‐Soluble Neutral Polysaccharide From Cantharellus cibarius and Its Immunostimulating Activity in RAW264.7 Cells.” International Journal of Polymeric Science 2017: 1–9. 10.1155/2017/3074915. [DOI] [Google Scholar]
  60. Chen, Q. , Qi C., Peng G., Liu Y., Zhang X., and Meng Z.. 2018. “Immune‐Enhancing Effects of a Polysaccharide PRG1‐1 From Russula griseocarnosa on RAW264.7 Macrophage Cells via the MAPK and NF‐κB Signalling Pathways.” Food and Agricultural Immunology 29: 833–844. 10.1080/09540105.2018.1461198. [DOI] [Google Scholar]
  61. Chen, W. W. , Zhang X., and Huang W. J.. 2016. “Role of Neuroinflammation in Neurodegenerative Diseases.” Molecular Medicine Reports 13: 3391–3396. 10.3892/mmr.2016.4948. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Chen, X. , and Xu B.. 2024. “Insights Into Chemical Components, Health‐Promoting Effects, and Processing Impact of Golden Chanterelle Mushroom Cantharellus cibarius .” Food & Function 15, no. 15: 7696–7732. 10.1039/d4fo00891j. [DOI] [PubMed] [Google Scholar]
  63. Chevalier, G. , and Frochot H.. 1997. La truffe de Bourgogne, 1–257. Levallois‐Perret, France: Éditions Pétrarque. [Google Scholar]
  64. Chin, K. L. , Khanal S., Hankins G. R., Perla V., and Qi Y.. 2018. “Anti‐Tumor Cell Growth by Extracts of Two Wild‐Collected Mushrooms.” Acta Scientific Agriculture 2: 43–47. [Google Scholar]
  65. Christofides, A. , Konstantinidou E., Jani C., and Boussiotis V. A.. 2021. “The Role of Peroxisome Proliferator‐Activated Receptors (PPAR) in Immune Responses.” Metabolism 114: 1–51. 10.1016/j.metabol.2020.154338. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Cieniecka‐Rosłonkiewicz, A. , Sas A., Przybysz E., Morytz B., Syguda A., and Pernak J.. 2007. “Ionic Liquids for the Production of Insecticidal and Microbicidal Extracts of the Fungus Cantharellus cibarius .” Chemistry & Biodiversity 4: 2218–2224. 10.1002/cbdv.200790179. [DOI] [PubMed] [Google Scholar]
  67. Clark, R. B. 2002. “The Role of PPARs in Inflammation and Immunity.” Journal of Leukocyte Biology 71: 388–400. [PubMed] [Google Scholar]
  68. Clarke, S. D. , Thuillier P., Baillie R. A., and Sha X.. 1999. “Peroxisome Proliferator‐Activated Receptors: A Family of Lipid‐Activated Transcription Factors.” American Journal of Clinical Nutrition 70: 566–571. 10.1093/ajcn/70.4.566. [DOI] [PubMed] [Google Scholar]
  69. Corner, E. J. H. 1966. A Monograph of Cantharelloid Fungi, 1–255. England, UK: Oxford University Press. [Google Scholar]
  70. Costa‐Silva, F. , Marques G., Matos C. C., Barros A. I. R. N. A., and Nunes F. M.. 2011. “Selenium Contents of Portuguese Commercial and Wild Edible Mushrooms.” Food Chemistry 126: 91–96. 10.1016/j.foodchem.2010.10.082. [DOI] [Google Scholar]
  71. Couto, S. R. , and Herrera J. L. T.. 2006. “Industrial and Biotechnological Applications of Laccases: A Review.” Biotechnology Advances 24, no. 5: 500–513. [DOI] [PubMed] [Google Scholar]
  72. Daliu, P. , Santini A., and Novellino E.. 2018. “A Decade of Nutraceutical Patents: Where Are We Now in 2018?” Expert Opinion on Therapeutic Patents 28: 1–8. 10.1080/13543776.2018.1552260. [DOI] [PubMed] [Google Scholar]
  73. Danell, E. 1994a. Cantharellus Cibarius: Mycorrhiza Formation and Ecology. Thesis, 1–75. Sweden: Uppsala University. [Google Scholar]
  74. Danell, E. 1994b. “Formation and Growth of the Ectomycorrhiza of Cantharellus cibarius .” Mycorrhiza 5: 89–97. 10.1007/bf00202339. [DOI] [Google Scholar]
  75. Danell, E. , and Camacho F.. 1997. “Successful Cultivation of the Golden Chanterelle.” Nature 385: 303. 10.1038/385303a0.9002511 [DOI] [Google Scholar]
  76. Daniewski, W. M. , Danikiewicz W., Gołębiewski W. M., et al. 2012. “Search for Bioactive Compounds From Cantharellus cibarius .” Natural Product Communications 7: 917–918. 10.1177/1934578X1200700729. [DOI] [PubMed] [Google Scholar]
  77. D'Archivio, M. , Filesi C., Varì R., Scazzocchio B., and Masella R.. 2010. “Bioavailability of the Polyphenols: Status and Controversies.” International Journal of Molecular Sciences 11: 1321–1342. 10.3390/ijms11041321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Das, A. K. , Nanda P. K., Dandapat P., et al. 2021. “Edible Mushrooms as Functional Ingredients for Development of Healthier and More Sustainable Muscle Foods: A Flexitarian Approach.” Molecules 26: 1–25. 10.3390/molecules26092463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. da Silva, M. C. , Naozuka J., Oliveira P. V., et al. 2010. “In Vivo Bioavailability of Selenium in Enriched Pleurotus ostreatus Mushrooms.” Metallomics 2: 162–166. 10.1039/b915780h. [DOI] [PubMed] [Google Scholar]
  80. De Assuncao, L. S. , da Luz J. M. R., da Silva M. D. C. S., et al. 2012. “Enrichment of Mushrooms: An Interesting Strategy for the Acquisition of Lithium.” Food Chemistry 134: 1123–1127. 10.1016/j.foodchem.2012.03.044. [DOI] [PubMed] [Google Scholar]
  81. De Kesel, A. D. , Amalfi M., Wa Ngoy B. K., et al. 2016. “New and Interesting Cantharellus From Tropical Africa.” Cryptogamie Mycologie 37: 283–327. 10.7872/crym/v37.iss3.2016.283. [DOI] [Google Scholar]
  82. Decker, E. A. 1997. “Phenolics: Prooxidants or Antioxidants?” Nutrition Reviews 55: 396–407. 10.1111/j.1753-4887.1997.tb01580.x. [DOI] [PubMed] [Google Scholar]
  83. Deo, G. S. , Khatra J., Buttar S., et al. 2019. “Antiproliferative, Immuno‐Stimulatory, and Anti‐Inflammatory Activities of Extracts Derived From Mushrooms Collected in Haida Gwaii, British Columbia (Canada).” International Journal of Medicinal Mushrooms 21: 629–643. 10.1615/IntJMedMushrooms.2019031193. [DOI] [PubMed] [Google Scholar]
  84. De‐Roman, M. , and Boa E.. 2006. “The Marketing of Lactarius deliciosus in Northern Spain.” Economic Botany 60: 284–290. 10.1663/0013-0001(2006)60[284:TMOLDI]2.0.CO;2. [DOI] [Google Scholar]
  85. Devkota, S. 2008. “Distribution and Status of Highland Mushrooms: A Case Study From Dolpa, Nepal.” Journal of Natural History Museum 23: 51–59. 10.3126/jnhm.v23i0.1839. [DOI] [Google Scholar]
  86. Diling, C. , Chaoqun Z., Jian Y., et al. 2017. “Immunomodulatory Activities of a Fungal Protein Extracted From Hericium erinaceus Through Regulating the Gut Microbiota.” Frontiers in Immunology 8: 1–22. 10.3389/fimmu.2017.00666. [DOI] [PMC free article] [PubMed] [Google Scholar]
  87. Dimitrijevic, M. V. , Mitic V. D., Jovanovic O. P., et al. 2018. “Comparative Study of Fatty Acids Profile in Eleven Wild Mushrooms of Boletacea and Russulaceae Families.” Chemistry & Biodiversity 15: 1–23. 10.1002/cbdv.201700434. [DOI] [PubMed] [Google Scholar]
  88. Dodor, D. E. , Hwang H. M., and Ekunwe S. I. N.. 2004. “Oxidation of Anthracene and Benzo[a]Pyrene by Immobilized Laccase From Trametes versicolor .” Enzyme and Microbial Technology 35: 210–217. 10.1016/j.enzmictec.2004.04.007. [DOI] [Google Scholar]
  89. Doyle, S. L. , and O'Neill L. A. J.. 2006. “Toll‐Like Receptors: From the Discovery of NF‐κB to New Insights Into Transcriptional Regulations in Innate Immunity.” Biochemical Pharmacology 72: 1102–1113. 10.1016/j.bcp.2006.07.010. [DOI] [PubMed] [Google Scholar]
  90. Drewnowska, M. , and Falandysz J.. 2015. “Investigation on Mineral Composition and Accumulation by Popular Edible Mushroom Common Chanterelle (Cantharellus cibarius).” Ecotoxicology and Environmental Safety 113: 9–17. 10.1016/j.ecoenv.2014.11.028. [DOI] [PubMed] [Google Scholar]
  91. Drewnowska, M. , Hanć A., Barałkiewicz D., and Falandysz J.. 2017. “Pickling of Chanterelle Cantharellus cibarius Mushrooms Highly Reduce Cadmium Contamination.” Environmental Science and Pollution Research 24: 21733–21738. 10.1007/s11356-017-9819-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  92. Dulger, B. , Gonuz A., and Gucin F.. 2004. “Antimicrobial Activity of the Macrofungus Cantharellus cibarius .” Pakistan Journal of Biological Sciences 7: 1535–1539. 10.3923/pjbs.2004.1535.1539. [DOI] [Google Scholar]
  93. Dziezak, J. D. 1986. “Preservatives: Antioxidants. The Ultimate Answer to Oxidation.” Food Technology 40: 94–102. [Google Scholar]
  94. Earle, F. S. 1905. “The Genera of the North American Gill Fungi.” Bulletin of the New York Botanical Garden 5: 373–383. [Google Scholar]
  95. Ebrahimzadeh, M. A. , Nabavi S. M., Nabavi S. F., Bahramian F., and Bekhradnia A. R.. 2010. “Antioxidant and free radical scavenging activity of H. officinalis L. var. angustifolius, V. odorata , B. hyrcana and C. speciosum .” Pakistan Journal of Pharmaceutical Sciences 23: 29–34. [PubMed] [Google Scholar]
  96. Ebrahimzadeh, M. A. , Safdari Y., and Khalili M.. 2015. “Antioxidant Activity of Different Fractions of Methanolic Extract of the Golden Chanterelle Mushroom Cantharellus cibarius (Higher Basidiomycetes) From Iran.” International Journal of Medicinal Mushrooms 17: 557–565. 10.1615/intjmedmushrooms.v17.i6.60. [DOI] [PubMed] [Google Scholar]
  97. Egli, S. , Peter M., Buser C., Stahel W., and Ayer F.. 2006. “Mushroom Picking Does Not Impair Future Harvests‐Results of a Long‐Term Study in Switzerland.” Biological Conservation 129: 271–276. 10.1016/j.biocon.2005.10.042. [DOI] [Google Scholar]
  98. Egwim, E. C. , Elem R. C., and Egwuche R. U.. 2011. “Proximate Composition, Phytochemical Screening and Antioxidant Activity of Ten Selected Wild Edible Nigerian Mushrooms.” American Journal of Food and Nutrition 1: 89–94. 10.5251/ajfn.2011.1.2.89.94. [DOI] [Google Scholar]
  99. Ehlers, T. , and Hobby T.. 2010. “The Chanterelle Mushroom Harvest on Northern Vancouver Island, British Columbia: Factors Relating to Successful Commercial Development.” Journal of Ecosystems and Management 11: 72–83. [Google Scholar]
  100. El Enshasy, H. A. , and Hatti‐Kaul R.. 2013. “Mushroom Immunomodulators: Unique Molecules With Unlimited Applications.” Trends in Biotechnology 31: 668–677. 10.1016/j.tibtech.2013.09.003. [DOI] [PubMed] [Google Scholar]
  101. El Khoury, D. , Cuda C., Luhovyy B. L., and Anderson G. H.. 2012. “Beta Glucan: Health Benefits in Obesity and Metabolic Syndrome.” Journal of Nutrition and Metabolism 2012: 1–28. 10.1155/2012/851362. [DOI] [PMC free article] [PubMed] [Google Scholar]
  102. Elmastas, M. , Isildak O., Turkekul I., and Temur N.. 2007. “Determination of Antioxidant Activity and Antioxidant Compounds in Wild Edible Mushrooms.” Journal of Food Composition and Analysis 20: 337–345. 10.1016/j.jfca.2006.07.003. [DOI] [Google Scholar]
  103. Erbiai, E. H. , da Silva L. P., Saidi R., Lamrani Z., da Silva J. C. E., and Maouni A.. 2021. “Chemical Composition, Bioactive Compounds, and Antioxidant Activity of Two Wild Edible Mushrooms Armillaria mellea and Macrolepiota procera From Two Countries (Morocco and Portugal).” Biomolecules 11: 575. 10.3390/biom11040575. [DOI] [PMC free article] [PubMed] [Google Scholar]
  104. Ergönül, P. G. , Akata I., Kalyoncu F., and Ergönül B.. 2013. “Fatty Acid Compositions of Six Wild Edible Mushroom Species.” Scientific World Journal 6: 1–5. 10.1155/2013/163964. [DOI] [PMC free article] [PubMed] [Google Scholar]
  105. Eyssartier, G. 2003. The Genus Cantharellus. PhD thesis. Paris, France: Muséum National d'Histoire Naturelle Paris. [Google Scholar]
  106. Eyssartier, G. , Stubbe D., Walleyn R., and Verbeken A.. 2009. “New Records of Cantharellus Species (Basidiomycota, Cantharellaceae) From Malaysian Dipterocarp Rainforest.” Fungal Diversity 36: 57–67. [Google Scholar]
  107. Falandysz, J. , and Borovička J.. 2013. “Macro and Trace Mineral Constituents and Radionuclides in Mushrooms: Health Benefits and Risks.” Applied Microbiology and Biotechnology 97: 477–501. 10.1007/s00253-012-4552-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  108. Falandysz, J. , and Drewnowska M.. 2015. “Macro and Trace Elements in Common Chanterelle (Cantharellus cibarius) Mushroom From the European Background Areas in Poland: Composition, Accumulation, Dietary Exposure and Data Review for Species.” Journal of Environmental Science and Health, Part B: Pesticides, Food Contaminants, and Agricultural Wastes 50: 374–387. 10.1080/03601234.2015.1000190. [DOI] [PubMed] [Google Scholar]
  109. Falandysz, J. , and Drewnowska M.. 2017. “Cooking Can Decrease Mercury Contamination of a Mushroom Meal: Cantharellus cibarius and Amanita fulva .” Environmental Science and Pollution Research International 24: 13352–13357. 10.1007/s11356-017-8933-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  110. Falandysz, J. , Widzicka E., Kojta A. K., et al. 2012. “Mercury in Common Chanterelles Mushrooms: Cantharellus spp. Update.” Food Chemistry 133, no. 3: 842–850. [Google Scholar]
  111. FAO STAT . 2019. Production Quantities of Mushrooms and Truffles by Country. FAOSTAT. Retrieved from. http://www.fao.org/faostat. [Google Scholar]
  112. Feeney, M. J. , Dwyer J., Hasler‐Lewis C. M., et al. 2014. “Mushrooms and Health Summit Proceedings.” Journal of Nutrition 144: 1128S–1136S. 10.3945/jn.114.190728. [DOI] [PMC free article] [PubMed] [Google Scholar]
  113. Fellows, P. J. 2017. Food Processing Technology: Principles and Practice. 4th ed. Cambridge, UK: Woodhead Publishing Series. [Google Scholar]
  114. Ferreira, I. , Barros L., and Abreu R.. 2009. “Antioxidants in Wild Mushrooms.” Current Medicinal Chemistry 16: 1543–1560. 10.2174/092986709787909587. [DOI] [PubMed] [Google Scholar]
  115. Finimundy, T. C. , Gambato G., Fontana R., et al. 2013. “Aqueous Extracts of Lentinula edodes and Pleurotus sajor‐caju Exhibit High Antioxidant Capability and Promising In Vitro Antitumor Activity.” Nutrition Research 33: 76–84. 10.1016/j.nutres.2012.11.005. [DOI] [PubMed] [Google Scholar]
  116. Foltz, M. J. , Perez K. E., and Volk T. J.. 2013. “Molecular Phylogeny and Morphology Reveal Three New Species of Cantharellus Within 20 m of One Another in Western Wisconsin, USA.” Mycologia 105: 447–461. 10.3852/12-181. [DOI] [PubMed] [Google Scholar]
  117. Fons, F. , Rapior S., Eyssartier G., and Bessiere J. M.. 2003. “Volatile Compounds in the Cantharellus, Craterellus and Hydnum Genera.” Cryptogamie Mycologie 24: 367–376. [Google Scholar]
  118. Fries, E. 1821. Systema Mycologicum, Sistens Fungorum Ordines, Genera et Species. Vols. I–II, Lund, Sweden: Berlingiana; Vols. III and Index. Greifswald, Germany: Ernesti Mauritiji. 10.5962/bhl.title.5378. [DOI] [Google Scholar]
  119. Fries, E. 1874. Hymenomycetes Europaei Sive Epicriseos Systematis Mycologici. 2nd ed. Uppsala, Sweden: Berligiana. [Google Scholar]
  120. Fuckel, L. 1870. “Symbolae mycologicae. Aus den Jahrbüchern des Nassauischen Vereins für Naturkunde.” 23–24: 1–459.
  121. Fukuda, T. , Uchida H., Takashima Y., Uwajima T., Kawabata T., and Suzuki M.. 2001. “Degradation of Bisphenol A by Purified Laccase From Trametes villosa .” Biochemical and Biophysical Research Communications 284: 704–706. 10.1006/bbrc.2001.5021. [DOI] [PubMed] [Google Scholar]
  122. Garzillo, A. M. , Colao M. C., Buonocore V., et al. 2001. “Structural and Kinetic Characterization of Native Laccases From Pleurotus ostreatus, Rigidoporus lignosus and Trametes trogii .” Journal of Protein Chemistry 20: 191–201. 10.1023/a:1010954812955. [DOI] [PubMed] [Google Scholar]
  123. Gill, M. , and Steglich W.. 1987. “Pigments of Fungi (Macromycetes).” Fortschritte der Chemie Organischer Naturstoffe 51: 1–317. 10.1007/978-3-7091-6971-1_1. [DOI] [PubMed] [Google Scholar]
  124. Giovannetti, G. , Roth‐Bejerano N., Zanini E., and Kagan‐Zur V.. 1994. “Truffles and Their Cultivation.” Horticultural Reviews 16: 71–107. 10.1002/9780470650561.ch3. [DOI] [Google Scholar]
  125. Guest, T. C. , and Rashid S.. 2016. “Anticancer Laccases: A Review.” Clinical & Experimental Oncology 5: 1–7. 10.4172/2324-9110.1000153. [DOI] [Google Scholar]
  126. Guo, M. , Meng M., Zhao J., Wang X., and Wang C.. 2020. “Immunomodulatory Effects of the Polysaccharide From Craterellus cornucopioides via Activating the TLR4‐NFkappaB Signaling Pathway in Peritoneal Macrophages of BALB/c Mice.” International Journal of Biological Macromolecules 160: 871–879. 10.1016/j.ijbiomac.2020.05.270. [DOI] [PubMed] [Google Scholar]
  127. Gutierrez, A. , Rencoret J., Ibarra D., et al. 2007. “Removal of Lipophilic Extractives From Paper Pulp by Laccase and Lignin‐Derived Phenols as Natural Mediators.” Environmental Science & Technology 41: 4124–4129. 10.1021/es062723+. [DOI] [PubMed] [Google Scholar]
  128. Hall, I. R. , Buchanan P. K., Yun W., and Cole A. L. J.. 1998. Edible and Poisonous Mushrooms: An Introduction. New Zealand: Crop and Food Research. [Google Scholar]
  129. Hall, I. R. , and Yun W.. 2000. “Edible Mushrooms as Secondary Crops in Forests.” Quarterly Journal of Forestry 94: 299–304. [Google Scholar]
  130. Han, C. K. , Chian H. C., Lin C. Y., Tang C. H., Lee H., and Huang D. D.. 2015. “Comparison of Immunomodulatory and Anticancer Activities in Different Strains of Tremella fuciformis Berk.” American Journal of Chinese Medicine 43: 1637–1655. 10.1142/S0192415X15500937. [DOI] [PubMed] [Google Scholar]
  131. Han, X. Q. , Li W. J., Ko C. H., Gao X. M., Han C. X., and Tu P. F.. 2013. “Structure Characterization and Immunocompetence of a Glucan From the Fruiting Bodies of Cantharellus cibarius .” Journal of Asian Natural Products Research 15: 1204–1209. 10.1080/10286020.2013.810212. [DOI] [PubMed] [Google Scholar]
  132. Harborne, J. B. , and Williams C. A.. 2000. “Advances in Flavonoid Research Since 1992.” Phytochemistry 55: 481–504. 10.1016/S0031-9422(00)00235-1. [DOI] [PubMed] [Google Scholar]
  133. Hawksworth, D. L. 1991. “The Fungal Dimension of Biodiversity, Magnitude, Significance, and Conservation.” Mycological Research 95: 641–655. 10.1016/S0953-7562(09)80810-1. [DOI] [Google Scholar]
  134. Hawksworth, D. L. 2012. “Global Species Numbers of Fungi: Are Tropical Studies and Molecular Approaches Contributing to a More Robust Estimate?” Biodiversity and Conservation 21: 2425–2433. 10.1007/s10531-012-0335-x. [DOI] [Google Scholar]
  135. Hawksworth, D. L. , and Lücking R.. 2017. “Fungal Diversity Revisited: 2.2 to 3.8 Million Species.” Microbiology Spectrum 5: 1–17. 10.1128/microbiolspec.FUNK-0052-2016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  136. Hay, W. D. 1887. An Elementary Text‐Book of British Fungi. Lowrey, London: S. Sonnenschein. [Google Scholar]
  137. He, M. Q. , Zhao R. L., Hyde K. D., et al. 2019. “Notes, Outline and Divergence Times of Basidiomycota.” Fungal Diversity 99: 105–367. 10.1007/s13225-019-00435-4. [DOI] [Google Scholar]
  138. Heitzer, T. , Schlinzig T., Krohn K., Meinertz T., and Münzel T.. 2001. “Endothelial Dysfunction, Oxidative Stress, and Risk of Cardiovascular Events in Patients With Coronary Artery Disease.” Circulation 104: 2673–2678. 10.1161/hc4601.099485. [DOI] [PubMed] [Google Scholar]
  139. Helen, A. , Krishnakumar K., Vijayammal P. L., and Augusti K. T.. 2000. “Antioxidant Effect of Onion Oil ( Allium cepa Linn.) on the Damages Induced by Nicotine in Rats as Compared to Alpha‐Tocopherol.” Toxicology Letters 116: 61–68. 10.1016/s0378-4274(00)00208-3. [DOI] [PubMed] [Google Scholar]
  140. Heleno, S. A. , Barros L., Martins A., et al. 2015. “Nutritional Value, Bioactive Compounds, Antimicrobial Activity and Bio Accessibility Studies With Wild Edible Mushrooms.” LWT‐Food Science and Technology 63: 799–806. 10.1016/j.lwt.2015.04.028. [DOI] [Google Scholar]
  141. Heleno, S. A. , Barros L., Sousa M. J., Martins A., and Ferreira I. C. F. R.. 2010. “Tocopherols Composition of Portuguese Wild Mushrooms With Antioxidant Capacity.” Food Chemistry 119: 1443–1450. 10.1016/j.foodchem.2009.09.025. [DOI] [Google Scholar]
  142. Heleno, S. A. , Ferreira R. C., Antonio A. L., Queiroz M. J. R. P., Barros L., and Ferreira I. C. F. R.. 2015. “Nutritional Value, Bioactive Compounds and Antioxidant Properties of Three Edible Mushrooms From Poland.” Food Bioscience 11: 48–55. 10.1016/j.fbio.2015.04.006. [DOI] [Google Scholar]
  143. Heleno, S. A. , Martins A., Queiroz M. J. R. P., and Ferreira I. C. F. R.. 2015. “Bioactivity of Phenolic Acids: Metabolites Versus Parent Compounds: A Review.” Food Chemistry 173: 501–513. 10.1016/j.foodchem.2014.10.057. [DOI] [PubMed] [Google Scholar]
  144. Henkel, T. W. , Wilson A. W., Amie M. C., et al. 2014. “Cantharellaceae of Guyana II: New Species of Craterellus, New South American Distribution Records for Cantharellus guyanensis and Craterellus excelsus, and a Key to the Neotropical Taxa.” Mycologia 106: 307–322. 10.3852/106.2.307. [DOI] [PubMed] [Google Scholar]
  145. Hibbett, D. S. , and Thorn R. G.. 2001. “Basidiomycota: Homobasidiomycetes.” In The Mycota, VIIB, edited by McLaughlin D. J., McLaughlin E. G., and Lemke P. A., 121–168. Berlin: Springer‐Verlag. [Google Scholar]
  146. Ho, L. H. , Zulkifli N. A., and Tan T. C.. 2020. “Edible Mushroom: Nutritional Properties, Potential Nutraceutical Values, and Its Utilisation in Food Product Development.” In An Introduction to Mushroom, edited by Passari A. K. and Sánchez S., 1–137. London, UK: IntechOpen. 10.5772/intechopen.91827. [DOI] [Google Scholar]
  147. Hong, J. , Bañuelos G. S., Fowler T., and Lin Z. Q.. 2011. “Use of Selenium‐Laden Plant Materials From Phytoremediation to Produce Selenium‐Biofortified Edible Mushrooms.” In ICOBTE 2011, 11th International Conference on the Biogeochemistry of Trace Elements. Conference Proceedings Parte I, 349–350. Florence, Italy: Congress Center. [Google Scholar]
  148. Hong, S. S. , Lee J. H., Jeong W., et al. 2012. “Acetylenic Acid Analogues From the Edible Mushroom Chanterelle (Cantharellus cibarius) and Their Effects on the Gene Expression of Peroxisome Proliferator‐Activated Receptor‐Gamma Target Genes.” Bioorganic & Medicinal Chemistry Letters 22: 2347–2349. 10.1016/j.bmcl.2012.01.070. [DOI] [PubMed] [Google Scholar]
  149. Hou, L. , Li Y., Chen M., and Li Z.. 2017. “Improved Fruiting of the Straw Mushroom (Volvariella volvacea) on Cotton Waste Supplemented With Sodium Acetate.” Applied Microbiology and Biotechnology 101: 8533–8541. 10.1007/s00253-017-8476-1. [DOI] [PubMed] [Google Scholar]
  150. Hou, H. , Zhou J., Wang J., Du C., and Yan B.. 2004. “Enhancement of Laccase Production by Pleurotus ostreatus and Its Use for the Decolorization of Anthraquinone Dye.” Process Biochemistry 39, no. 11: 1415–1419. [Google Scholar]
  151. Imberty, A. , Gautier C., Lescar J., Pérez S., Wyns L., and Loris R.. 2000. “An Unusual Carbohydrate Binding Site Revealed by the Structures of Two Maackia amurensis Lectins Complexed With Sialic Acid‐Containing Oligosaccharides.” Journal of Biological Chemistry 275: 17541–17548. 10.1074/jbc.M000560200. [DOI] [PubMed] [Google Scholar]
  152. Ina, K. , Kataoka T., and Ando T.. 2013. “The Use of Lentinan for Treating Gastric Cancer.” Anti‐Cancer Agents in Medicinal Chemistry 13: 681–688. 10.2174/1871520611313050002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  153. Izquierdo‐Vega, J. A. , Morales‐González J. A., Sánchez‐Gutiérrez M., et al. 2017. “Evidence of Some Natural Products With Antigenotoxic Effects. Part 1: Fruits and Polysaccharides.” Nutrients 9: 1–27. 10.3390/nu9020102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  154. Jablonska‐Rys, E. , Sławinska A., and Szwajgier D.. 2016. “Effect of Lactic Acid Fermentation on Antioxidant Properties and Phenolic Acid Contents of Oyster (Pleurotus ostreatus) and Chanterelle (Cantharellus cibarius) Mushrooms.” Food Science and Biotechnology 25: 439–444. 10.1007/s10068-016-0060-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  155. Jana, P. , and Acharya K.. 2020. “Mushroom: A New Resource for Anti‐Angiogenic Therapeutics.” Food Review International 38: 88–109. 10.1080/87559129.2020.1721529. [DOI] [Google Scholar]
  156. Jansen, E. , and Van Dobben H. F.. 1987. “Is Decline of Cantharellus cibarius in The Netherlands due to Air Pollution?” Ambio 16: 211–213. http://www.jstor.org/stable/4313357. [Google Scholar]
  157. Jaouani, A. , Guillen F., Penninckx M. J., Martinez A. T., and Martinez M. J.. 2005. “Role of Pycnoporus coccineus Laccase in the Degradation of Aromatic Compounds in Olive Oil Mill Wastewater.” Enzyme and Microbial Technology 36: 478–486. 10.1016/j.enzmictec.2004.11.011. [DOI] [Google Scholar]
  158. Jasim, A. 2017. “Medicinal Properties of Laccase From Basidiomycetes Mushroom: A Review.” Advances in Life Science and Technology 54: 99–109. [Google Scholar]
  159. Jayachandran, M. , Zhang T., Ganesan K., Xu B., and Chung S. S. M.. 2018. “Isoquercetin Ameliorates Hyperglycemia and Regulates Key Enzymes of Glucose Metabolism via Insulin Signaling Pathway in Streptozotocin‐Induced Diabetic Rats.” European Journal of Pharmacology 829: 112–120. 10.1016/j.ejphar.2018.04.015. [DOI] [PubMed] [Google Scholar]
  160. Jentschke, G. , Godbold D. L., and Hütterman A.. 1991. “Culture of Mycorrhizal Tree Seedlings Under Controlled Conditions: Effects of Nitrogen and Aluminium.” Physiologia Plantarum 81: 408–416. 10.1111/j.1399-3054.1991.tb08751.x. [DOI] [Google Scholar]
  161. Jiang, Q. 2014. “Natural Forms of Vitamin E: Metabolism, Antioxidant, and Anti‐Inflammatory Activities and Their Role in Disease Prevention and Therapy.” Free Radical Biology & Medicine 72: 76–90. 10.1016/j.freeradbiomed.2014.03.035. [DOI] [PMC free article] [PubMed] [Google Scholar]
  162. Jin, W. J. , and Lu X. X.. 2011. “Study on Extraction Cantharellus cibarius Polysaccharaide and Its Antioxidant Activity.” Journal of Anhui Agricultural University 39: 16545–16550. [Google Scholar]
  163. Jones, S. , and Janardhanan K. K.. 2000. “Antioxidant and Antitumor Activity of Ganoderma lucidum (Curt.:Fr.) P.Karst.‐Reishi (Aphyllophoromycetidae) From South India.” International Journal of Medicinal Mushrooms 2: 195–200. 10.1615/IntJMedMushr.v2.i3.20. [DOI] [Google Scholar]
  164. Kakon, A. , Choudhury M. B. K., and Saha S.. 2012. “Mushroom Is an Ideal Food Supplement.” journal of the Dhaka Medical College 18: 58–62. 10.3329/jdnmch.v18i1.12243. [DOI] [Google Scholar]
  165. Kała, K. , Krakowska A., Gdula‐Argasińska J., Opoka W., and Muszyńska B.. 2019. “Assessing the Bioavailability of Zinc and Indole Compounds From Mycelial Cultures of the Bay Mushroom Imleria badia (Agaricomycetes) Using In Vitro Models.” International Journal of Medicinal Mushrooms 21: 343–352. 10.1615/IntJMedMushrooms.2019030328. [DOI] [PubMed] [Google Scholar]
  166. Kała, K. , Krakowska A., Sułkowska‐Ziaja K., et al. 2017. “Kinetics of Extracted Bioactive Components From Mushrooms in Artificial Digestive Juices.” International Journal of Food Properties 20: 1796–1817. 10.1080/10942912.2016.1219742. [DOI] [Google Scholar]
  167. Kala, K. , Krakowskab A., Ziebac P., Opokab W., and Muszynsk B.. 2021. “Effect of Conservation Methods on the Bioaccessibility of Bioelements From In Vitro‐Digested Edible Mushrooms.” Journal of the Science of Food and Agriculture 101: 3481–3488. 10.1002/jsfa.10979. [DOI] [PubMed] [Google Scholar]
  168. Kalac, P. 2009. “Chemical Composition and Nutritional Value of European Species of Wild Growing Mushrooms: A Review.” Food Chemistry 113: 9–16. 10.1016/j.foodchem.2008.07.077. [DOI] [Google Scholar]
  169. Kalac, P. 2010. “Trace Element Contents in European Species of Wild Growing Edible Mushrooms: A Review for the Period 2000–2009.” Food Chemistry 122: 2–15. 10.1016/j.foodchem.2010.02.045. [DOI] [Google Scholar]
  170. Kalac, P. 2013. “A Review of Chemical Composition and Nutritional Value of Wild‐Growing and Cultivated Mushrooms.” Journal of the Science of Food and Agriculture 93: 209–218. 10.1002/jsfa.5960. [DOI] [PubMed] [Google Scholar]
  171. Kalaras, M. D. , Beelman R. B., and Elias R. J.. 2012. “Effects of Postharvest Pulsed Uv Light Treatment of White Button Mushrooms (Agaricus bisporus) on Vitamin D2 Content and Quality Attributes.” Journal of Agricultural and Food Chemistry 60: 220–225. 10.1021/jf203825e. [DOI] [PubMed] [Google Scholar]
  172. Kalra, E. K. 2003. “Nutraceutical‐ Definition and Introduction.” American Association of Pharmaceutical Scientists 5: 27–28. 10.1208/ps050325. [DOI] [Google Scholar]
  173. Kao, C. , Jesuthasan A. C., Bishop K. S., Glucina M. P., and Ferguson L. R.. 2013. “Anti‐Cancer Activities of Ganoderma lucidum: Active Ingredients and Pathways.” Functional Foods in Health and Disease 3: 48–65. 10.31989/ffhd.v3i2.65. [DOI] [Google Scholar]
  174. Karamyshev, A. V. , Shleev S. V., Koroleva O. V., Yaropolov A. I., and Sakharov I. Y.. 2003. “Laccase‐Catalyzed Synthesis of Conducting Polyaniline.” Enzyme and Microbial Technology 33: 556–564. 10.1016/S0141-0229(03)00163-7. [DOI] [Google Scholar]
  175. Kaur, G. , Kalia A., and Sodhi H. S.. 2017. “Selenium Biofortification of Pleurotus Species and Its Effect on Yield, Phytochemical Profiles, and Protein Chemistry of Fruiting Bodies.” Journal of Food Biochemistry 42: 1–7. 10.1111/jfbc.12467. [DOI] [Google Scholar]
  176. Kavishree, S. , Hemavathy J., Lokesh B. R., Shashirekha M. N., and Rajarathnam S.. 2008. “Fat and Fatty Acids of Indian Edible Mushrooms.” Food Chemistry 106: 597–602. 10.1016/j.foodchem.2007.06.018. [DOI] [Google Scholar]
  177. Khatun, S. , Islam A., Cakilcioglu U., and Chatterjee N. C.. 2012. “Research on Mushroom as a Potential Source of Nutraceuticals: A Review on Indian Perspective.” American Journal of Experimental Agriculture 2: 47–73. 10.9734/AJEA/2012/492. [DOI] [Google Scholar]
  178. Kim, J. A. , Tay D., and de Blanco E. C.. 2008. “NF‐kappaB Inhibitory Activity of Compounds Isolated From Cantharellus cibarius .” Phytotherapy Research 22: 1104–1106. 10.1002/ptr.2467. [DOI] [PubMed] [Google Scholar]
  179. Kobayashi, H. , Inokuchi N., Koyama T., et al. 1992. “Primary Structure of a Base Nonspecific and Adenylic Acid Preferential Ribonuclease From the Fruit Bodies of Lentinus edodes .” Bioscience, Biotechnology, and Biochemistry 56: 2003–2010. 10.1271/bbb.56.2003. [DOI] [PubMed] [Google Scholar]
  180. Kolundzic, M. , Stanojkovic T., Radovic J., et al. 2017. “Cytotoxic and Antimicrobial Activities of Cantharellus cibarius Fr. (Cantarellaceae).” Journal of Medicinal Food 20: 790–796. 10.1089/jmf.2016.0176. [DOI] [PubMed] [Google Scholar]
  181. Kosanic, M. , Rankovic B., and Dasic M.. 2013. “Antioxidant and Antimicrobial Properties of Mushrooms.” Bulgarian Journal of Agricultural Science 19: 1040–1046. [Google Scholar]
  182. Kozarski, M. , Klaus A., Vunduk J., et al. 2015. “Nutraceutical Properties of the Methanolic Extract of Edible Mushroom Cantharellus cibarius (Fries): Primary Mechanisms.” Food & Function 6: 1875–1886. 10.1039/C5FO00312A. [DOI] [PubMed] [Google Scholar]
  183. Kumari, D. , Reddy M. S., and Upadhyay R. C.. 2011. “Nutritional Composition and Antioxidant Activities of 18 Different Wild Cantharellus Mushrooms of Northwestern Himalayas.” Food Science and Technology International 17: 557–567. 10.1177/1082013211427620. [DOI] [PubMed] [Google Scholar]
  184. Kumari, D. , Upadhyay R. C., and Reddy M. S.. 2011. “Cantharellus Pseudoformosus, a New Species Associated With Cedrus deodara From India.” Mycoscience 52: 147–151. 10.1007/s10267-010-0080-5. [DOI] [Google Scholar]
  185. Lai, C. Y. , Yang L. C., and Lin W. C.. 2015. “Type II Arabinogalactan From Anoectochilus formosanus Induced Dendritic Cell Maturation Through tlr 2 and tlr4.” Phytomedicine 22: 1207–1214. 10.1016/j.phymed.2015.10.010. [DOI] [PubMed] [Google Scholar]
  186. Lakhanpal, T. N. , and Rana M.. 2005. “Medicinal and Nutraceutical Genetic Resources of Mushrooms.” Plant Genetic Resources 3: 288–303. 10.1079/PGR200581. [DOI] [Google Scholar]
  187. Lam, S. K. , and Ng T. B.. 2001a. “First Simultaneous Isolation of a Ribosome Inactivating Protein and an Antifungal Protein From a Mushroom (Lyophyllum shimeiji) Together With Evidence for Synergism of Their Antifungal Effects.” Archives of Biochemistry and Biophysics 393: 271–280. 10.1006/abbi.2001.2506. [DOI] [PubMed] [Google Scholar]
  188. Lam, S. K. , and Ng T. B.. 2001b. “Hypsin, a Novel Thermostable Ribosome‐Inactivating Protein With Antifungal and Antiproliferative Activities From Fruiting Bodies of the Edible Mushroom Hypsizigus marmoreus .” Biochemical and Biophysical Research Communications 285: 1071–1075. 10.1006/bbrc.2001.5279. [DOI] [PubMed] [Google Scholar]
  189. Lam, Y. , Ng T., and Wang H.. 2001. “Antiproliferative and Antimitogenic Activities in a Peptide From Puffball Mushroom Calvatia caelata .” Biochemical and Biophysical Research Communications 289: 744–749. 10.1006/bbrc.2001.6036. [DOI] [PubMed] [Google Scholar]
  190. Larsson, K. H. 1997. Swedish Red Data Book of Fungi 1997, 1–547. Uppsala, Sweden: Artdatabanken, Swedish University of Agricultural Sciences. [Google Scholar]
  191. Le Marchand, L. 2002. “Cancer Preventive Effects of Flavonoids‐a Review.” Biomedicine & Pharmacotherapy 56: 296–301. 10.1016/s0753-3322(02)00186-5. [DOI] [PubMed] [Google Scholar]
  192. Lemieszek, M. K. , Marques P. S., Ribeiro M., et al. 2019. “Mushroom Small RNAs as Potential Anticancer Agents: A Closer Look at Cantharellus cibarius Proapoptotic and Antiproliferative Effects in Colon Cancer Cells.” Food & Function 10: 2739–2751. 10.1039/c8fo02378f. [DOI] [PubMed] [Google Scholar]
  193. Lemieszek, M. K. , Nunes F. M., Cardoso C., Marques G., and Rzesk W.. 2018. “Neuroprotective Properties of Cantharellus cibarius Polysaccharide Fractions in Different In Vitro Models of Neurodegeneration.” Carbohydrate Polymers 197: 598–607. 10.1016/j.carbpol.2018.06.038. [DOI] [PubMed] [Google Scholar]
  194. Lemieszek, M. K. , Nunes F. M., Marques G., and Rzeski W.. 2019. “ Cantharellus cibarius Branched Mannans Inhibits Colon Cancer Cells Growth by Interfering With Signals Transduction in NF‐ĸB Pathway.” International Journal of Biological Macromolecules 134: 770–780. 10.1016/j.ijbiomac.2019.05.072. [DOI] [PubMed] [Google Scholar]
  195. Lemieszek, M. K. , Nunes F. M., and Rzeski W.. 2019. “Branched Mannans From the Mushroom Cantharellus cibarius Enhance the Anticancer Activity of Natural Killer Cells Against Human Cancers of Lung and Colon.” Food & Function 10: 5816–5826. 10.1039/C9FO00510B. [DOI] [PubMed] [Google Scholar]
  196. Lewis, C. T. 1891. An Elementary Latin Dictionary. New York: Harper & Brothers. [Google Scholar]
  197. Li, H. , Tian Y., Menolli N. Jr., et al. 2021. “Reviewing the World's Edible Mushroom Species: A New Evidence‐Based Classification System.” Comprehensive Reviews in Food Science and Food Safety 20: 1982–2014. 10.1111/1541-4337.12708. [DOI] [PubMed] [Google Scholar]
  198. Li, J. , Lin J. C., Wang H., Peterson J. W., Furie B. C., and Furie B.. 2003. “Novel Role of Vitamin k in Preventing Oxidative Injury to Developing Oligodendrocytes and Neurons.” Journal of Neuroscience 23: 5816–5826. 10.1523/JNEUROSCI.23-13-05816.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  199. Lindequist, U. , Niedermeyer T. H., and Jülich W. D.. 2005. “The Pharmacological Potential of Mushrooms.” Evidence‐Based Complementary and Alternative Medicine 2: 285–299. 10.1093/ecam/neh107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  200. Linnaeus, C. 1747. Wästgöta‐resa, förrättad år 1746, 1–304. Stockholm, Sweden. [Google Scholar]
  201. Linnaeus, C. 1755. [1986 reprint]. Svensk flora = Flora svecica. [Utgiven i samarbete med Svenska Linné‐sällskapet], 1–482. Stockholm, Sweden: Linnean press. [Google Scholar]
  202. Liu, D. , Cheng H., Bussmann R. W., Guo Z., Liu B., and Long C.. 2018. “An Ethnobotanical Survey of Edible Fungi in Chuxiong City, Yunnan, China.” Journal of Ethnobiology and Ethnomedicine 14: 1–10. 10.1186/s13002-018-0239-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  203. Lobelius, M. 1581. Plantarum seu stirpium icones. Tomus II, 273–276. Antwerp, Belgium: Christophori Plantini. [Google Scholar]
  204. Lovrić, M. , Da Re R., Vidale E., et al. 2020. “Nonwood Forest Products in Europe—A Quantitative Overview.” Forest Policy and Economics 116: 1–9. 10.1016/j.forpol.2020.102175. [DOI] [Google Scholar]
  205. Lovrić, M. , Da Re R., Vidale E., et al. 2021. “Collection and Consumption of Non‐wood Forest Products in Europe.” Journal of Forest Research 94: 757–770. 10.1093/forestry/cpab018. [DOI] [Google Scholar]
  206. Lu, R. , and Xia L. M.. 2004. “Advances in Research and Application of Laccase Mediator System.” Xianweisu Kexue Yu Jishu 12: 37–44. [Google Scholar]
  207. Lu, X. , Brennan M. A., Narciso J., et al. 2020. “Correlations Between the Phenolic and Fibre Composition of Mushrooms and the Glycaemic and Textural Characteristics of Mushroom Enriched Extruded Products.” LWT‐Food Science and Technology 118: 1–43. 10.1016/j.lwt.2019.108730. [DOI] [Google Scholar]
  208. Luginina, E. A. , and Sorokina A. A.. 2021. “Parameters of Cantharellus cibarius Fr. Ecological Range Fragment and Resilience to Human Impact in Taiga and Sub Taiga Forest Communities.” IOP Conference Series: Earth and Environmental Science 677: 1–7. 10.1088/1755-1315/677/5/052077. [DOI] [Google Scholar]
  209. Ma, G. , Wenjian Y., Liyan Z., Fei P., Donglu F., and Qiuhui H.. 2018. “A Critical Review on the Health Promoting Effects of Mushrooms Nutraceuticals.” Food Science and Human Wellness 7: 125–133. 10.1016/j.fshw.2018.05.002. [DOI] [Google Scholar]
  210. Mallavadhani, U. V. , Akella V. S., Sudhakar K. V. S., Satyanarayana A. M., Li W., and VanBreemen R. B.. 2006. “Chemical and Analytical Screening of Some Edible Mushrooms.” Food Chemistry 95: 58–64. 10.1016/j.foodchem.2004.12.018. [DOI] [Google Scholar]
  211. Mallikarjuna, E. S. , Ranjini A. J., Haware D., Vijyalakshmi M. R., Shashirekha M. N., and Rajarathnam S.. 2013. “Mineral Composition of Four Edible Mushrooms.” Journal of Chemistry 2013: 1–5. 10.1155/2013/805284. [DOI] [Google Scholar]
  212. Manzi, P. , Marconi S., Aguzzi A., and Pizzoferrato L.. 2004. “Commercial Mushrooms: Nutritional Quality and Effect Cooking.” Food Chemistry 84: 201–206. 10.1016/S0308-8146(03)00202-4. [DOI] [Google Scholar]
  213. Marathe, S. J. , Hamzi W., Bashein A. M., et al. 2021. “Anti‐Angiogenic Effect of Cantharellus cibarius Extracts, Its Correlation With Lipoxygenase Inhibition, and Role of the Bioactives Therein.” Nutrition and Cancer 74: 724–734. 10.1080/01635581.2021.1909739. [DOI] [PubMed] [Google Scholar]
  214. Marcal, S. , Sousa A. S., Taofiq O., et al. 2021. “Impact of Postharvest Preservation Methods on Nutritional Value and Bioactive Properties of Mushrooms.” Trends in Food Science and Technology 110: 418–431. 10.1016/j.tifs.2021.02.007. [DOI] [Google Scholar]
  215. Martinez‐Medina, G. A. , Chávez‐González M. L., Verma D. K., et al. 2021. “Bio‐Funcional Components in Mushrooms, a Health Opportunity: Ergothionine and Huitlacohe as Recent Trends.” Journal of Functional Foods 77: 1–17. 10.1016/j.jff.2020.104326. [DOI] [Google Scholar]
  216. Marty‐Detraves, C. , Francis F., Baricault L., Fournier D., and Paquereau L.. 2004. “Inhibitory Action of a New Lectin From Xerocomus Chrysenteron on Cell‐Substrate Adhesion.” Molecular and Cellular Biochemistry 258: 49–55. 10.1023/B:MCBI.0000012835.08001.8f. [DOI] [PubMed] [Google Scholar]
  217. Mattila, P. , Konko K., Eurola M., et al. 2001. “Contents of Vitamins, Mineral Elements, and Some Phenolic Compounds in Cultivated Mushrooms.” Journal of Agricultural and Food Chemistry 49: 2343–2348. 10.1021/jf001525d. [DOI] [PubMed] [Google Scholar]
  218. Mattila, P. , Suonpää K., and Piironen V.. 2000. “Functional Properties of Edible Mushrooms.” Nutrition 16: 694–696. 10.1016/s0899-9007(00)00341-5. [DOI] [PubMed] [Google Scholar]
  219. Mau, J. L. , Miklus M. B., and Beelman R. B.. 1993. “The Shelf Life of Agaricus Mushrooms.” In Shelf Life Studies of Foods and Beverages, edited by Charalambous G., 255–288. Science Publishers, Amsterdam: Elsevier. [Google Scholar]
  220. McKnight, K. H. , and McKnight V. B.. 1987. Peterson Field Guides: A Field Guide to Mushrooms, 1–429. Boston, MA: Houghton Mifflin Co. [Google Scholar]
  221. McLaughlin, D. J. 1970. “Environmental Control of Fruit Body Development in Boletus rubinellus in Axenic Culture.” Mycologia 62: 307–331. 10.1080/00275514.1970.12018970. [DOI] [PubMed] [Google Scholar]
  222. Méndez‐Espinoza, C. , García‐Nieto E., Esquivel A. M., et al. 2013. “Antigenotoxic Potential of Aqueous Extracts From the Chanterelle Mushroom, Cantharellus cibarius (Higher Basidiomycetes), on Human Mononuclear Cell Cultures.” International Journal of Medicinal Mushrooms 15: 325–332. 10.1615/intjmedmushr.v15.i3.90. [DOI] [PubMed] [Google Scholar]
  223. Meng, Y. , Qun Y., Wu W., et al. 2019. “Galactan Isolated From Cantharellus cibarius Modulates Antitumor Immune Response by Converting Tumor‐Associated Macrophages Toward M1‐Like Phenotype.” Carbohydrate Polymers 226: 1–10. 10.1016/j.carbpol.2019.115295. [DOI] [PubMed] [Google Scholar]
  224. Michniewicz, A. , Ledakowicz S., Ullrich R., and Hofrichter M.. 2008. “Kinetics of the Enzymatic Decolorization of Textile Dyes by Laccase From Cerrena unicolor .” Dyes and Pigments 77: 295–302. 10.1016/j.dyepig.2007.05.015. [DOI] [Google Scholar]
  225. Mier, N. , Canete S., Klaebe A., Chavant L., and Fournier D.. 1996. “Insecticidal Properties of Mushroom and Toadstool Carpophores.” Phytochemistry 41: 1293–1299. 10.1016/0031-9422(95)00773-3. [DOI] [PubMed] [Google Scholar]
  226. Mikolasch, A. , Hammer E., Jonas U., Popowski K., Stielow A., and Schauer F.. 2002. “Synthesis of 3‐(3,4‐Dihydroxyphenyl)‐propionic Acid Derivatives by N‐Coupling of Amines Using Laccase.” Tetrahedron 58: 7589–7593. 10.1016/S0040-4020(02)00872-4. [DOI] [Google Scholar]
  227. Mitchell, D. , and Hobby T.. 2010. “From Rotations to Revolutions: Non‐Timber Forest Products and the New World of Forest Management.” BC Journal of Ecosystems and Management 11: 27–28. 10.22230/jem.2010v11n1&2a58. [DOI] [Google Scholar]
  228. Mittermeier, V. K. , Dunkel A., and Hofmann T.. 2018. “Discovery of Taste Modulating Octadecadien‐12‐Ynoic Acids in Golden Chanterelles (Cantharellus cibarius).” Food Chemistry 269: 53–62. 10.1016/j.foodchem.2018.06.123. [DOI] [PubMed] [Google Scholar]
  229. Mokochinski, J. B. , López B. G. C., Sovrani V., et al. 2015. “Production of Agaricus brasiliensis Mycelium From Food Industry Residues as a Source of Antioxidants and Essential Fatty Acids.” International Journal of Food Science and Technology 50: 2052–2058. 10.1111/ijfs.12861. [DOI] [Google Scholar]
  230. Molina, R. , O'Dell T., Luoma D., Amaranthus M., Castellano M., and Russell K.. 1993. Biology, Ecology and Social Aspects of Wild Edible Mushrooms in the Forests of the Pacific Northwest: A Preface to Managing Commercial Harvest, 1–42. Portland, Oregon, USA: U.S. Department of Agriculture, Forest Service, Pacific Northwest Research Station. [Google Scholar]
  231. Moncalvo, J. , Nilsson R. H., Koster B., et al. 2006. “The Cantharelloid Clade: Dealing With Incongruent Gene Trees and Phylogenetic Reconstruction Methods.” Mycologia 98: 937–948. 10.1080/15572536.2006.11832623. [DOI] [PubMed] [Google Scholar]
  232. Moro, C. , Palacios I., Lozano M., et al. 2012. “Anti‐Inflammatory Activity of Methanolic Extracts From Edible Mushrooms in LPS Activated RAW 264.7 Macrophages.” Food Chemistry 130: 350–355. 10.1016/j.foodchem.2011.07.049. [DOI] [Google Scholar]
  233. Murugesan, K. 2003. “Bioremediation of Paper and Pulp Mill Effluents.” Indian Journal of Experimental Biology 41: 1239–1248. [PubMed] [Google Scholar]
  234. Muszyńska, B. , Kała K., Firlej A., and Sułkowska‐Ziaja K.. 2016. “ Cantharellus cibarius‐ Culinary‐Medicinal Mushroom Content and Biological Activity.” Acta Poloniae Pharmaceutica—Drug Research 73: 589–598. [PubMed] [Google Scholar]
  235. Muszyńska, B. , Sułkowska‐Ziaja K., and Ekiert H.. 2011. “Indole Compounds in Fruiting Bodies of Some Edible Basidiomycota Species.” Food Chemistry 125: 1306–1308. 10.1016/j.foodchem.2010.10.056. [DOI] [Google Scholar]
  236. Muszyńska, B. , Zając M., Kała K., Rojowski J., and Opoka W.. 2016. “Thermal Processing Can Affect Zinc Availability in Some Edible Mushrooms.” LWT‐Food Science and Technology 69: 424–429. 10.1016/j.lwt.2016.01.078. [DOI] [Google Scholar]
  237. Nantel, P. , and Neumann P.. 1992. “Ecology of Ectomycorrhizal Basidiomycete Communities on a Local Vegetation Gradient.” Ecology 73: 99–117. 10.2307/1938724. [DOI] [Google Scholar]
  238. Nasiry, D. , Khalatbary A. R., and Ebrahimzadeh M. A.. 2017. “Anti‐Inflammatory and Wound‐Healing Potential of Golden Chanterelle Mushroom, Cantharellus cibarius (Agaricomycetes).” International Journal of Medicinal Mushrooms 19: 893–903. 10.1615/IntJMedMushrooms.2017024674. [DOI] [PubMed] [Google Scholar]
  239. Ncanana, S. , and Burton S.. 2007. “Oxidation of 8‐Hydroxyquinoline Catalyzed by Laccase From Trametes pubescens Yields an Antioxidant Aromatic Polymer.” Journal of Molecular Catalysis B: Enzymatic 44: 66–71. 10.1016/j.molcatb.2006.09.005. [DOI] [Google Scholar]
  240. Ng, T. B. 2004. “Peptides and Proteins From Fungi.” Peptides 26: 1055–1073. 10.1016/j.peptides.2004.03.013. [DOI] [PubMed] [Google Scholar]
  241. Ng, T. B. , and Wang H. X.. 2004. “A Homodimeric Laccase With Unique Characteristics From the Yellow Mushroom Cantharellus cibarius .” Biochemical and Biophysical Research Communications 313: 37–41. 10.1016/j.bbrc.2003.11.087. [DOI] [PubMed] [Google Scholar]
  242. Niazi, A. R. , and Ghafoor A.. 2021. “Different Ways to Exploit Mushrooms: A Review.” All Life 14: 450–460. 10.1080/26895293.2021.1919570. [DOI] [Google Scholar]
  243. Nielsen, S. R. , and Schmid M. C.. 2017. “Macrophages as Key Drivers of Cancer Progression and Metastasis.” Mediators of Inflammation 2017: 1–12. 10.1155/2017/9624760. [DOI] [PMC free article] [PubMed] [Google Scholar]
  244. Norvell, L. L. 1992a. “Fungus‐Tree Partnership Provokes Innovative Study.” Western Forester 37: 22. [Google Scholar]
  245. Norvell, L. L. 1992b. “Studying the Effects of Harvesting on Chanterelle Productivity in Oregon's Mt. Hood National Forest.” In Wild Mushroom Harvesting Discussion Session Minutes, edited by De Geus P. M. J., Redhead S., and Callan B., 9–15. Victoria, BC: British Columbia Ministry of Forests, Pacific Forestry Centre. [Google Scholar]
  246. Novak, M. , and Vetvicka V.. 2008. “β‐Glucans, History, and the Present: Immunomodulatory Aspects and Mechanisms of Action.” Journal of Immunotoxicology 5: 47–57. 10.1080/15476910802019045. [DOI] [PubMed] [Google Scholar]
  247. Novaković, S. , Đekic I., Klaus A., et al. 2020. “Antioxidant Activity of Mushrooms In Vitro and in Frankfurters.” Meat Technology 61: 62–69. 10.18485/meattech.2020.61.1.5. [DOI] [Google Scholar]
  248. Novakovic, S. , Djekic I., Klaus A., et al. 2019. “The Effect of Cantharellus cibarius Addition on Quality Characteristics of Frankfurter During Refrigerated Storage.” Food 8: 1–12. 10.3390/foods8120635. [DOI] [PMC free article] [PubMed] [Google Scholar]
  249. Nowacka, N. , Nowak R., Drozd M., Olech M., and Los R.. 2014. “Analysis of Phenolic Constituents, Antiradical and Antimicrobial Activity of Edible Mushrooms Growing Wild in Poland.” LWT‐Food Science and Technology 59: 689–694. 10.1016/j.lwt.2014.05.041. [DOI] [Google Scholar]
  250. Nowacka‐Jechalke, N. , Olech M., and Nowak R.. 2018. “Mushroom Polyphenols as Chemopreventive Agents.” In Polyphenols: Prevention and Treatment of Human Disease, edited by Watson R. R., Preedy V. R., and Zibadi S., 137–150. Cambridge, MA: Academic Press. [Google Scholar]
  251. Nwofor, S. C. , Morenikeji O. A., Adeoye‐Isijola O., and Morenike O. T. O.. 2018. “Inhibitory Activities of Ethanolic Extracts of Two Macrofungi Against Eggs and Miracidia of Fasciola spp.” Open Life Sciences 13: 504–510. 10.1515/biol-2018-0060. [DOI] [PMC free article] [PubMed] [Google Scholar]
  252. Nyman, A. A. T. , Aachmann F. L., Rise F., Balance S., and Samuelsen A. B. C.. 2016. “Structural Characterization of a Branched (1→6)‐ α‐Mannan and β‐Glucans Isolated From the Fruiting Bodies of Cantharellus cibarius .” Carbohydrate Polymers 146: 197–207. 10.1016/j.carbpol.2016.03.052. [DOI] [PubMed] [Google Scholar]
  253. Ogawa, W. , Endo N., Fukuda M., and Yamada A.. 2018. “Phylogenetic Analyses of Japanese Golden Chanterelles and a New Species Description, Cantharellus anzutake sp. nov.” Mycoscience 59: 153–165. 10.1016/j.myc.2017.08.014. [DOI] [Google Scholar]
  254. Okan, O. T. , Yildiz S., Yilmaz A., Barutçiyan J., and Deniz I.. 2014. “Wild Edible Mushrooms Having an Important Potential in East Black Sea Region.” International Caucasian Forestry Symposium: 673–680. [Google Scholar]
  255. Okhuoya, J. A. , Akpaja E. O., Osemwegie O. O., Oghenekaro A. O., and Ihayere C. A.. 2010. “Nigerian Mushrooms: Underutilized Non‐wood Forest Resources.” Journal of Applied Sciences and Environmental Management 14: 43–54. 10.4314/jasem.v14i1.56488. [DOI] [Google Scholar]
  256. Olariaga, I. , Moreno G., Manjón J. L., et al. 2017. “Cantharellus (Cantharellales, Basidiomycota) Revisited in Europe Through a Multigene Phylogeny.” Fungal Diversity 83: 263–292. 10.1007/s13225-016-0376-7. [DOI] [Google Scholar]
  257. Ooi, V. 2008. “Antitumor and Immunomodulatory Activities of Mushroom Polysaccharides.” In Mushrooms as Functional Foods, edited by Cheung P., 147–198. Hoboken: Wiley & Sons Inc.. 10.1002/9780470367285.ch5. [DOI] [Google Scholar]
  258. Oskoueian, E. , Abdullah N., Saad W. Z., et al. 2011. “Antioxidant, Anti‐Inflammatory and Anticancer Activities of Methanolic Extracts From Jatropha curcas Linn.” Journal of Medicinal Plant Research: Planta Medica 5: 49–57. [Google Scholar]
  259. Ouzouni, P. K. , Petridis D., Koller W. D., and Riganakos K. A.. 2009. “Nutritional Value and Metal Content of Wild Edible Mushrooms Collected From West Macedonia and Epirus, Greece.” Food Chemistry 115: 1575–1580. 10.1016/j.foodchem.2009.02.014. [DOI] [Google Scholar]
  260. Ozturk, B. , Havsut E., and Yıldız K.. 2021. “Delaying the Postharvest Quality Modifications of Cantharellus cibarius Mushroom by Applying Citric Acid and Modified Atmosphere Packaging.” LWT‐Food Science and Technology 138: 1–6. 10.1016/j.lwt.2020.110639. [DOI] [Google Scholar]
  261. Ozturk, M. , Tel‐Çayan G., Muhammad A., Terzioğlu P., and Duru M. E.. 2015. “Mushrooms: A Source of Exciting Bioactive Compounds.” In Studies in Natural Products Chemistry, edited by Rahman A. U., 363–456. Amsterdam, Netherlands: Elsevier. 10.1016/B978-0-444-63473-3.00010-1. [DOI] [Google Scholar]
  262. Palacios, I. , Lozano M., Moro C., et al. 2011. “Antioxidant Properties of Phenolic Compounds Occurring in Edible Mushrooms.” Food Chemistry 128: 674–678. 10.1016/j.foodchem.2011.03.085. [DOI] [Google Scholar]
  263. Palmieri, G. , Cennamo G., and Sannia G.. 2005. “Remazol Brilliant Blue R Decolourisation by the Fungus Pleurotus Ostreatus and Its Oxidative Enzymatic System.” Enzyme and Microbial Technology 36: 17–24. 10.1016/j.enzmictec.2004.03.026. [DOI] [Google Scholar]
  264. Palmieri, G. , Giardina P., Desiderio B., Marzullo L., Giamberini M., and Sannia G.. 1993. “A New Enzyme Immobilization Procedure Using Copper Alginate Gel: Application to a Fungal Phenol Oxidase.” Enzyme and Microbial Technology 16: 151–158. 10.1016/0141-0229(94)90078-7. [DOI] [PubMed] [Google Scholar]
  265. Panchak, L. V. , Antonyuk L. Y., Zyn A. R., and Antonyuk V.. 2020. “Extractive Substances of Fruit Body Golden Chanterelle (Cantharellus cibarius Fr.) and Hedgehog Mushroom (Hydnum repandum Fr.).” Emirates Journal of Food and Agriculture 32: 826–834. 10.9755/ejfa.2020.v32.i11.2195. [DOI] [Google Scholar]
  266. Panche, A. N. , Diwan A. D., and Chandra S. R.. 2016. “Flavonoids: An Overview.” Journal of Nutritional Science 5: 1–15. 10.1017/jns.2016.41. [DOI] [PMC free article] [PubMed] [Google Scholar]
  267. Pang, Z. , and Sterner O.. 1991. “Cibaric Acid, a New Fatty Acid Derivative Formed Enzymatically in Damaged Fruit Bodies of Cantharellus cibarius (Chanterelle).” Journal of Organic Chemistry 56: 1233–1235. 10.1021/JO00003A054. [DOI] [Google Scholar]
  268. Papoutsis, K. , Grasso S., Menon A., et al. 2020. “Recovery of Ergosterol and Vitamin D2 From Mushroom Waste‐Potential Valorization by Food and Pharmaceutical Industries.” Trends in Food Science and Technology 99: 351–366. 10.1016/j.tifs.2020.03.005. [DOI] [Google Scholar]
  269. Patel, S. , and Goyal A.. 2012. “Recent Developments in Mushrooms as Anti‐Cancer Therapeutics: A Review.” 3 Biotech 2: 1–15. 10.1007/s13205-011-0036-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  270. Paul, B. D. , and Snyder S. H.. 2010. “The Unusual Amino Acid L‐Ergothioneine Is a Physiologic Cytoprotectant.” Cell Death and Differentiation 17: 1134–1140. 10.1038/cdd.2009.163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  271. Pegler, D. N. , Roberts P. J., and Spooner B. M.. 1997. British Chanterelles and Tooth Fungi, 1–114. Kew: Royal Botanic Gardens. [Google Scholar]
  272. Persson, O. , and Mossberg B.. 1997. The Chanterelle Book, 1–120. Berkeley, CA: Ten Speed Press. [Google Scholar]
  273. Peters, J. , Shah Y., and Gonzalez F.. 2012. “The Role of Peroxisome Proliferator‐Activated Receptors in Carcinogenesis and Chemoprevention.” Nature Reviews. Cancer 12: 181–195. 10.1038/nrc3214. [DOI] [PMC free article] [PubMed] [Google Scholar]
  274. Petersen, R. H. 1971a. “The Genera Gomphus and Gloeocantharellus in North America.” Nova Hedwigia 21: 1–112. [Google Scholar]
  275. Petersen, R. H. 1971b. “Interfamilial Relationships in the Clavarioid and Cantharelloid Fungi.” In Evolution in the Higher Basidiomycetes, edited by Petersen R. H., 345–374. Knoxville, TN: University of Tennessee Press. [Google Scholar]
  276. Petersen, R. H. 1985. “Notes on Clavarioid Fungi. XIX. Colored Illustrations of Selected Taxa, With Comments on Cantharellus.” Nova Hedwigia 42: 151–169. [Google Scholar]
  277. Phat, C. , Moon B., and Lee C.. 2016. “Evaluation of Umami Taste in Mushroom Extracts by Chemical Analysis, Sensory Evaluation, and an Electronic Tongue System.” Food Chemistry 192: 1068–1077. 10.1016/j.foodchem.2015.07.113. [DOI] [PubMed] [Google Scholar]
  278. Pilz, D. , Molina R., and Mayo J.. 2006. “Effects of Thinning Young Forests on Chanterelle Mushroom Production.” Journal of Forestry 104: 9–14. 10.1093/jof/104.1.9. [DOI] [Google Scholar]
  279. Pilz, D. , Norvell L., Danell E., and Molina R.. 2003. Ecology and Management of Commercially Harvested Chanterelle Mushrooms, 1–83. Portland: U.S. Department of Agriculture, Pacific Northwest Research Station. [Google Scholar]
  280. Politowicz, J. , Lech K., Sánchez‐Rodríguez L., Szumny A., and Carbonell‐Barrachina Á. A.. 2017. “Volatile Composition and Sensory Profile of Cantharellus cibarius Fr. as Affected by Drying Method.” Journal of the Science of Food and Agriculture 97: 5223–5232. 10.1002/jsfa.8406. [DOI] [PubMed] [Google Scholar]
  281. Popova, T. P. 2015. “Investigations on Antimicrobial Activity In Vitro of Liquid Cultures of Cantharellus cibarius .” International Journal of Current Microbiology and Applied Sciences 4: 674–683. [Google Scholar]
  282. Prasad, S. , Rathore H., Sharma S., and Yadav A. S.. 2015. “Medicinal Mushrooms as a Source of Novel Functional Food.” International Journal of Food Science and Nutrition 4: 221–225. 10.19070/2326-3350-1500040. [DOI] [Google Scholar]
  283. Purvis, A. , and Hector A.. 2000. “Getting the Measure of Biodiversity.” Nature 405: 212–219. 10.1038/35012221. [DOI] [PubMed] [Google Scholar]
  284. Puttaraju, N. G. , Venkateshaiah S. U., Dharmesh S. M., Urs S. M., and Somasundaram R.. 2006. “Antioxidant Activity of Indigenous Edible Mushrooms.” Journal of Agricultural and Food Chemistry 54: 9764–9772. 10.1021/jf0615707. [DOI] [PubMed] [Google Scholar]
  285. Pyysalo, H. 1976. “Identification of Volatile Compounds in Seven Edible Fresh Mushrooms.” Acta Chemica Scandinavica 30: 235–244. 10.3891/acta.chem.scand.30b-0235. [DOI] [Google Scholar]
  286. Quélet, L. 1888. Flore mycologique de la France et de pays limitrophes. Paris, France: O. Doin. [Google Scholar]
  287. Rahi, D. K. , and Malik D.. 2016. “Diversity of Mushrooms and Their Metabolites of Nutraceutical and Therapeutic Significance.” Journal of Mycology 2016: 1–18. 10.1155/2016/7654123. [DOI] [Google Scholar]
  288. Rajarathnam, S. , Shashirekha M. N., and Bano Z.. 1998. “Biodegradative and Biosynthetic Capacities of Mushrooms: Present and Future Strategies.” Critical Reviews in Biotechnology 18: 91–236. 10.1080/0738-859891224220. [DOI] [PubMed] [Google Scholar]
  289. Raman, J. , Lee S. K., Im J. H., Oh M. J., Oh Y. L., and Jang K. Y.. 2018. “Current Prospects of Mushroom Production and Industrial Growth in India.” Journla of Mushrooms 16: 239–249. 10.14480/JM.2018.16.4.239. [DOI] [Google Scholar]
  290. Ramesh, C. H. , and Pattar M. G.. 2010. “Antimicrobial Properties, Antioxidant Activity and Bioactive Compounds From Six Wild Edible Mushrooms of Western Ghats of Karnataka, India.” Pharmacognosy Research 2: 107–112. 10.4103/0974-8490.62953. [DOI] [PMC free article] [PubMed] [Google Scholar]
  291. Rangel‐Castro, J. I. 2001. Eco‐Physiology of the Ectomycorrhizal Mushroom Cantharellus Cibarius: Carbon and Nitrogen Metabolism, and the Interactions With Bacteria and Mycophagous Inverterbrates. PhD thesis. Uppsala, Sweden: Department of Forest Mycology and Pathology, Swedish University of Agricultural Sciences. [Google Scholar]
  292. Rangel‐Castro, J. I. , Staffas A., and Danell E.. 2002. “The Ergocalciferol Content of Dried Pigmented and Albino Cantharellus cibarius Fruit Bodies.” Mycological Research 106: 70–73. 10.1017/S0953756201005299. [DOI] [Google Scholar]
  293. Rao, A. V. , and Rao L. G.. 2007. “Carotenoids and Human Health.” Pharmacological Research 55: 207–216. 10.1016/j.phrs.2007.01.012. [DOI] [PubMed] [Google Scholar]
  294. Rathee, S. , Rathee D., Rathee D., Kumar V., and Rathee P.. 2012. “Mushrooms as Therapeutic Agents.” Revista Brasileira de Farmacognosia 22: 459–474. 10.1590/S0102-695X2011005000195. [DOI] [Google Scholar]
  295. Rathore, H. , Prasad S., Kapri M., Tiwari A., and Sharma S.. 2019. “Medicinal Importance of Mushroom Mycelium: Mechanisms and Applications.” Journal of Functional Foods 56: 182–193. 10.1016/j.jff.2019.03.016. [DOI] [Google Scholar]
  296. Redhead, S. A. , Norvell L., and Danell E.. 1997. “ Cantharellus formosus and the Pacific Golden Chanterelle Harvest in Western North America.” Mycotaxon 65: 285–322. [Google Scholar]
  297. Reis, F. S. , Barros L., Martins A., and Ferreira I. C. F. R.. 2012. “Chemical Composition and Nutritional Value of the Most Widely Appreciated Cultivated Mushrooms: An Inter‐Species Comparative Study.” Food and Chemical Toxicology 50: 191–197. 10.1016/j.fct.2011.10.056. [DOI] [PubMed] [Google Scholar]
  298. Reis, F. S. , Heleno S. A., Barros L., et al. 2011. “Toward the Antioxidant and Chemical Characterization of Mycorrhizal Mushrooms From Northeast Portugal.” Journal of Food Science 76: C824–C830. 10.1111/j.1750-3841.2011.02251.x. [DOI] [PubMed] [Google Scholar]
  299. Reis, F. S. , Martins A., Vasconcelos M. H., Morales P., and Ferreira I. C. F. R.. 2017. “Functional Foods Based on Extracts or Compounds Derived From Mushrooms.” Trends in Food Science and Technology 66: 48–62. 10.1016/j.tifs.2017.05.010. [DOI] [Google Scholar]
  300. Ren, J. , Shi J. L., Han C. C., Liu Z. Q., and Guo J. Y.. 2012. “Isolation and Biological Activity of Triglycerides of the Fermented Mushroom of Coprinus comatus .” BMC Complementary and Alternative Medicine 12: 1–5. 10.1186/1472-6882-12-52. [DOI] [PMC free article] [PubMed] [Google Scholar]
  301. Research and Markets . 2021. “Global edible Mushrooms Market‐Industry Trends, Opportunities and Forecasts to 2023.” Accessed March 20, 2021. https://www.researchandmarkets.com/reports/4451952/global‐edible‐mushrooms‐market‐industry‐trends.
  302. Ribeiro, B. , De Pinho P. G., Andrade P. B., Baptista P., and Valentão P.. 2009. “Fatty Acid Composition of Wild Edible Mushrooms Species: A Comparative Study.” Microchemical Journal 93: 29–35. 10.1016/j.microc.2009.04.005. [DOI] [Google Scholar]
  303. Ricciotti, E. , and FitzGerald G. A.. 2011. “Prostaglandins and Inflammation.” Arteriosclerosis, Thrombosis, and Vascular Biology 31: 986–1000. 10.1161/ATVBAHA.110.207449. [DOI] [PMC free article] [PubMed] [Google Scholar]
  304. Richard‐Greenblatt, M. , Bach H., Adamson J., et al. 2015. “Regulation of Ergothioneine Biosynthesis and Its Effect on mycobacterium tuberculosis Growth and Infectivity.” Journal of Biological Chemistry 290: 23064–23076. 10.1074/jbc.M115.648642. [DOI] [PMC free article] [PubMed] [Google Scholar]
  305. Romagnesi, H. 1995. “Prodrome a une flore analytique des hymenomycetes agaricoides III. Fam. Cantharellaceae Schroeter.” Documents Mycologiques 25: 417–424. [Google Scholar]
  306. Rowe, R. F. 1997. “The Commercial Harvesting of Wild Edible Mushrooms in the Pacific Northwest Region of the United States.” Mycologist 11: 10–15. 10.1016/S0269-915X(97)80060-2. [DOI] [Google Scholar]
  307. Royse, D. J. , Baars J., and Tan Q.. 2017. “Current Overview of Mushroom Production in the World.” In Edible Medicinal Mushrooms: Technology and Applications, edited by Diego C. Z. and Pardo‐Giménez A., 5–13. Hoboken, NJ: John Wiley & Sons Ltd. 10.1002/9781119149446.ch2. [DOI] [Google Scholar]
  308. Ruthes, A. C. , Smiderle F. R., and Iacomini M.. 2016. “Mushroom Heteropolysaccharides: A Review on Their Sources, Structure and Biological Effects.” Carbohydrate Polymers 136: 358–375. 10.1016/j.carbpol.2015.08.061. [DOI] [PubMed] [Google Scholar]
  309. Salihovic, M. , Pazalja M., Huremović M., Ajanović A., and Tahirović I.. 2021. “Chemical Ingredients of Fresh and Dry Wild Mushrooms From Bosnia and Herzegovina.” Asian Journal of Pharmaceutical Research and Health Care 13: 244–253. 10.18311/ajprhc/2021/27646. [DOI] [Google Scholar]
  310. Salihovic, M. , Sapcanin A., Pehlic E., Uzunovic A., Spirtovic‐Halilovic S., and Huremovic M.. 2019. “Amino Acids Composition and Antioxidant Activity of Selected Mushrooms From Bosnia and Herzegovina.” Kemija u Industriji 68: 97–103. 10.15255/KUI.2018.034. [DOI] [Google Scholar]
  311. Sánchez, C. 2017. “Reactive Oxygen Species and Antioxidant Properties From Mushrooms.” Synthetic and Systems Biotechnology 2: 13–22. 10.1016/j.synbio.2016.12.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  312. Sande, D. , de Oliveira G. P., Moura M. A. F., de Almeida M. B., Lima M. T. N. S., and Takahashi J. A.. 2019. “Edible Mushrooms as a Ubiquitous Source of Essential Fatty Acids.” Food Research International 125: 1–16. 10.1016/j.foodres.2019.108524. [DOI] [PubMed] [Google Scholar]
  313. Santoyo, S. , Ramírez‐Anguiano A. C., Reglero G., and Soler‐Rivas C.. 2009. “Improvement of the Antimicrobial Activity of Edible Mushroom Extracts by Inhibition of Oxidative Enzymes.” International Journal of Food Science and Technology 44: 1057–1064. 10.1111/j.1365-2621.2008.01896.x. [DOI] [Google Scholar]
  314. Sarikurcku, C. , Tepe B., Kocak M. S., and Uren M. C.. 2015. “Metal Concentration and Antioxidant Activity of Edible Mushrooms From Turkey.” Food Chemistry 175: 549–555. 10.1016/j.foodchem.2014.12.019. [DOI] [PubMed] [Google Scholar]
  315. Satyanarayana, S. , Sekhar J. R., Kumar K. E., Shannika L. B., Rajanna B., and Rajanna S.. 2006. “Influence of Selenium (Antioxidant) on Gliclazide Induced Hypoglycaemia/Anti Hyperglycaemia in Normal/Alloxan‐Induced Diabetic Rats.” Molecular and Cellular Biochemistry 283: 123–127. 10.1007/s11010-006-2387-2. [DOI] [PubMed] [Google Scholar]
  316. Sawangwan, T. , Wansanit W., Pattani L., and Noysang C.. 2018. “Study of Prebiotic Properties From Edible Mushroom Extraction.” Agriculture and Natural Resources 52: 519–524. 10.1016/j.anres.2018.11.020. [DOI] [Google Scholar]
  317. Schlosser, W. W. , and Blatner K. A.. 1994. “The Wild Edible Mushroom Industry of Washington, Oregon and Idaho: A 1992 Survey of Processors.” In U.S. Department of Agriculture Forest Service, Pacific Northwest Forests and Range Experiment Station. Oregon, USA: Corvallis, OR. [Google Scholar]
  318. Senila, M. , Senila L., and Resz M. A.. 2024. “Chemical Composition and Nutritional Characteristics of Popular Wild Edible Mushroom Species Collected From North‐Western Romania.” Journal of Food Composition and Analysis 134: 106504. [Google Scholar]
  319. Shamtsyan, M. 2010. “Bioactive Compounds in Mushrooms.” In Encyclopedia of Biotechnology in Agriculture and Food, edited by Heldman D. R., Wheeler M. B., and Hoover D. G.. Abingdon, Oxfordshire, UK: Taylor & Francis. 10.1081/E-EBAF-120045515. [DOI] [Google Scholar]
  320. Shao, S. C. , Liu P. G., Wei T. Z., and Herrera M.. 2021. “New Insights Into the Taxonomy of the Genus Cantharellus in China: Epityfication of C. yunnanensis W.F. Chiu and the First Record of C. cibarius Fr.” Cryptogamie Mycologie 42: 25–37. 10.5252/cryptogamie-mycologie2021v42a3. [DOI] [Google Scholar]
  321. Shao, S. C. , Tian X. F., and Liu P. G.. 2011. “Cantharellus in Southwestern China: A New Species and a New Record.” Mycotaxon 116: 437–446. 10.5248/116.437. [DOI] [Google Scholar]
  322. Sharma, D. , Singh V. P., and Singh N. K.. 2018. “A Review on Phytochemistry and Pharmacology of Medicinal as Well as Poisonous Mushrooms.” Mini‐Reviews in Medicinal Chemistry 18: 1095–1109. 10.2174/1389557517666170927144119. [DOI] [PubMed] [Google Scholar]
  323. She, Q. B. , Ng T. B., and Liu W. K.. 1998. “A Novel Lectin With Potent Immunomodulatory Activity Isolated From Both Fruiting Bodies and Cultured Mycelia of the Edible Mushroom Volvariella volvacea .” Biochemical and Biophysical Research Communications 247: 106–111. 10.1006/bbrc.1998.8744. [DOI] [PubMed] [Google Scholar]
  324. Shen, H. S. , Shao S., Chen J. C., and Zhou T.. 2017. “Antimicrobials From Mushrooms for Assuring Food Safety.” Comprehensive Reviews in Food Science and Food Safety 16: 316–329. 10.1111/1541-4337.12255. [DOI] [PubMed] [Google Scholar]
  325. Sies, H. , Stahl W., and Sundquist A. R.. 1992. “Antioxidant Functions of Vitamins. Vitamins E and C, Beta‐Carotene, and Other Carotenoids.” Annals of the new York Academy of Sciences 669: 7–20. 10.1111/j.1749-6632.1992.tb17085.x. [DOI] [PubMed] [Google Scholar]
  326. Siju, P. , Ghetia R., Vadher B., and Manvar M. N.. 2015. “In‐Vitro Anti‐Inflammatory Activity of Fractions of Ailanthus Excelsa Roxb. By HRBC Membrane Stabilization.” Asian Journal of Pharmacy and Technology 5: 29–31. 10.5958/2231-5713.2015.00006.9. [DOI] [Google Scholar]
  327. Silva, B. M. , Andrade P. B., Valentao P., Ferreres F., Seabra R. M., and Ferreira M. A.. 2004. “Quince ( Cydonia oblonga Miller) Fruit (Pulp, Peel, and Seed) and Jam: Antioxidant Activity.” Journal of Agricultural and Food Chemistry 52: 4705–4712. 10.1021/jf040057v. [DOI] [PubMed] [Google Scholar]
  328. Sinbad, O. O. , Folorunsho A. A., Olabisi O. L., Ayoola O. A., and Temitope E. J.. 2019. “Vitamins as Antioxidants.” Journal of Food Science and Nutrition Research 2: 214–235. 10.26502/jfsnr.2642-11000021. [DOI] [Google Scholar]
  329. Singh, B. P. , and Passari A. K.. 2018. Biology of Macrofungi. Switzerland: Springer Cham. [Google Scholar]
  330. Singh, R. S. , Bhari R., and Kaur H. P.. 2010. “Mushroom Lectins: Current Status and Future Perspectives.” Critical Reviews in Biotechnology 30: 99–126. 10.3109/07388550903365048. [DOI] [PubMed] [Google Scholar]
  331. Siriwardhana, N. , Kalupahana N. S., Cekanova M., LeMieux M., Greer B., and Moustaid‐Moussa N.. 2013. “Modulation of Adipose Tissue Inflammation by Bioactive Food Compounds.” Journal of Nutritional Biochemistry 24: 613–623. 10.1016/j.jnutbio.2012.12.013. [DOI] [PubMed] [Google Scholar]
  332. Slee, R. W. 1991. “The Potential of Small Woodlands in Britain for Edible Mushroom Production.” Scottish Forestry 45: 3–12. [Google Scholar]
  333. Smith, A. H. , and Morse E. E.. 1947. “The Genus Cantharellus in the Western United States.” Mycologia 39: 497–534. 10.2307/3755192. [DOI] [PubMed] [Google Scholar]
  334. Smolskaitė, L. , Venskutonis P. R., and Talou T.. 2015. “Comprehensive Evaluation of Antioxidant and Antimicrobial Properties of Different Mushroom Species.” LWT‐Food Science and Technology 60: 462–471. 10.1016/j.lwt.2014.08.007. [DOI] [Google Scholar]
  335. Soobrattee, M. A. , Neergheen V. S., Luximon‐Ramma A., Aruoma O. I., and Bahorun T.. 2005. “Phenolics as Potential Antioxidant Therapeutic Agents: Mechanism and Actions.” Mutation Research. Fundamental and molecular mechanisms of mutagenesis 579: 200–213. 10.1016/j.mrfmmm.2005.03.023. [DOI] [PubMed] [Google Scholar]
  336. Stamets, P. 2000. Growing Gourmet and Medicinal Mushrooms, 1–267. Bekerly: Ten Speed Press. [Google Scholar]
  337. Steinhauser, G. , and Steinhauser V.. 2016. “A Simple and Rapid Method for Reducing Radiocesium Concentrations in Wild Mushrooms (Cantharellus and Boletus) in the Course of Cooking.” Journal of Food Protection 79: 1995–1999. [DOI] [PubMed] [Google Scholar]
  338. Sumic, Z. , Tepic A., Vidovic S., Jokic S., and Malbasa R.. 2013. “Optimization of Frozen Sour Cherries Vacuum Drying Process.” Food Chemistry 136: 55–63. 10.1016/j.foodchem.2012.07.102. [DOI] [PubMed] [Google Scholar]
  339. Sumic, Z. , Tepic A., Vidovic S., Vakula A., Vladic J., and Pavlic B.. 2016. “Process Optimization of Chanterelle (Cantharellus cibarius) Mushrooms Vacuum Drying.” Journal of Food Processing & Preservation 41: 1–12. 10.1111/jfpp.12822. [DOI] [Google Scholar]
  340. Tam, S. C. , Yip K. P., Fung K. P., and Chang S. T.. 1986. “Hypotensive and Renal Effects of an Extract of the Edible Mushroom Pleurotus sajorcaju .” Life Sciences 38: 1155–1161. 10.1016/0024-3205(86)90169-4. [DOI] [PubMed] [Google Scholar]
  341. Tan, B. , Norhaizan M. E., Liew W. P., and Rahman H. S.. 2018. “Antioxidant and Oxidative Stress: A Mutual Interplay in Age‐Related Diseases.” Frontiers in Pharmacology 9: 1–28. 10.3389/fphar.2018.01162. [DOI] [PMC free article] [PubMed] [Google Scholar]
  342. Taylor, T. N. , Remy W., and Hass H.. 1994. “Allomyces in the Devonian.” Nature 367: 601. 10.1038/367601a0. [DOI] [Google Scholar]
  343. Tedder, S. , Mitchell D. A., and Farran R.. 2000. Seeing the Forest Beneath the Trees: The Social and Economic Potential of Non‐timber Forest Products and Services in the Queen Charlotte Islands/Haida Gwaii. South Moresby Replacement Account. [Google Scholar]
  344. Tekeli, Y. , Dogan H. H., and Uslu U.. 2008. “Determination of Antioxidant Activity of Cantharellus cibarius Fr.” Asian Journal of Chemistry 20: 2381–2384. [Google Scholar]
  345. Thakur, M. P. 2018. “Advances in Postharvest Technology and Value Additions of Edible Mushrooms.” Indian Phytopathology 71: 303–315. 10.1007/s42360-018-0060-9. [DOI] [Google Scholar]
  346. Thu, Z. M. , Myo K. K., Aung H. T., Clericuzio M., Armijos C., and Vidari G.. 2020. “Bioactive Phytochemical Constituents of Wild Edible Mushrooms From Southeast Asia.” Molecules 25: 1–38. 10.3390/molecules25081972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  347. Tibuhwa, D. , Buyck B., Kivaisi A., and Tibell L.. 2008. “ Cantharellus Fistulosus sp. nov. From Tanzania.” Cryptogamie Mycologie 29: 129–135. [Google Scholar]
  348. Tinggi, U. 2008. “Selenium: Its Role as Antioxidant in Human Health.” Environmental Health and Preventive Medicine 13: 102–108. 10.1007/s12199-007-0019-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  349. Tinoco, R. , Pickard M. A., and Vazquez‐Duhalt R.. 2001. “Kinetic Differences of Purified Laccases From Six Pleurotus ostreatus Strains.” Letters in Applied Microbiology 32: 331–335. 10.1046/j.1472-765x.2001.00913.x. [DOI] [PubMed] [Google Scholar]
  350. Tsyganov, M. A. , Vishnivetskaya G. B., Kukina T. P., et al. 2018. “Effects of the Mushroom Cantharellus cibarius on the Liver Fluke O. Felineus and Hosting Inbreed C57BL/6 Mice.” Journal of Genetics and Breeding 22: 850–858. 10.18699/VJ18.426. [DOI] [Google Scholar]
  351. Turfan, N. , Ayan S., Akın S. S., and Akın E.. 2019. “Nutritional and Antioxidant Variability of Some Wild and Cultivated Edible Mushrooms From Kastamonu Rural Areas.” Turkish Journal of Agriculture‐Food Science and Technology 7: 11–16. 10.24925/turjaf.v7isp3.11-16.3094. [DOI] [Google Scholar]
  352. Ugbogu, E. A. , Emmanuel O., Ude V. C., Ijioma S. N., Ugbogu O. C., and Akubugwo E. I.. 2020. “Nutritional Composition and Toxicity Profile of Cantharellus Species (Purple Mushroom) in Rats.” Scientific African 8: 1–10. 10.1016/j.sciaf.2020.e00375. [DOI] [Google Scholar]
  353. Ustun, O. , Kaiser M., and Tasdemir D.. 2011. “Antiprotozoal and Cytotoxic Activities of Some Mushrooms From Turkey.” Planta Medica 77: PL32. 10.1055/s-0031-1282681. [DOI] [Google Scholar]
  354. Uthan, E. T. , Senturk H., Uyanoglu M., and Yamaç M.. 2021. “First Report on the In Vivo Prebiotic, Biochemical, and Histological Effects of Crude Polysaccharide Fraction of Golden Chantharelle Mushroom, Cantharellus cibarius (Agaricomycetes).” International Journal of Medicinal Mushrooms 23: 67–77. 10.1615/IntJMedMushrooms.2021038233. [DOI] [PubMed] [Google Scholar]
  355. Uzun, Y. , Alkan S., İrende İ., İlhan H., Çavuşoğlu Ş., and Aslan A.. 2023. “Assessment of Some Nutrient Contents and Heavy Metal Accumulation in Some Wild Edible Mushrooms in Türkiye.” Mantar Dergisi 14, no. 2: 69–77. [Google Scholar]
  356. Valentao, P. , Andrade P. B., Rangel J., et al. 2005. “Effect of the Conservation Procedure on the Contents of Phenolic Compounds and Organic Acids in Chanterelle (Cantharellus cibarius) Mushroom.” Journal of Agricultural and Food Chemistry 53: 4925–4931. 10.1021/jf0580263. [DOI] [PubMed] [Google Scholar]
  357. Valverde, M. E. , Hernández‐Pérez T., and Paredes‐López O.. 2015. “Edible Mushrooms: Improving Human Health and Promoting Quality Life.” International Journal of Microbiology 2015: 1–14. 10.1155/2015/376387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  358. Vasdekis, E. P. , Karkabounas A., Giannakopoulos I., Savvas D., and Lekka M. E.. 2018. “Screening of Mushrooms Bioactivity: Piceatannol Was Identified as a Bioactive Ingredient in the Order Cantharellales.” European Food Research and Technology 244: 861–871. 10.1007/s00217-017-3007-y. [DOI] [Google Scholar]
  359. Vetter, J. 1994. “Mineral Elements in the Important Cultivated Mushrooms Agaricus bisporus and Pleurotus osteratus .” Food Chemistry 50: 277–279. 10.1016/0308-8146(94)90132-5. [DOI] [Google Scholar]
  360. Vetvicka, V. , Vashishta A., Saraswat‐Ohri S., and Vetvickova J.. 2008. “Immunological Effects of Yeast‐ and Mushroom‐Derived β‐Glucans.” Journal of Medicinal Food 11: 615–622. 10.1089/jmf.2007.0588. [DOI] [PubMed] [Google Scholar]
  361. Villares, A. , García‐Lafuente A., Guillamón E., and MateoVivaracho L.. 2013. “Separation and Characterization of the Structural Features of Macromolecular Carbohydrates From Wild Edible Mushrooms.” Bioactive Carbohydrates and Dietary Fibre 2: 15–21. 10.1016/j.bcdf.2013.08.004. [DOI] [Google Scholar]
  362. Vlasenko, V. , Turmunkh D., Ochirbat E., et al. 2019. “Medicinal Potential of Extracts From the Chanterelle Mushroom, Cantharellus Cibarius (Review) and Prospects for Studying Its Strains From Differs Plant Communities of Ultracontinental Regions of the Asia.” Bio Web of Conferences 16: 1–4. 10.1051/bioconf/20191600039. [DOI] [Google Scholar]
  363. Wakai, S. , Arazoe T., Ogino T., and Kondo A.. 2017. “Future Insights in Fungal Metabolic Engineering.” Bioresource Technology 245: 1314–1326. 10.1016/j.biortech.2017.04.095. [DOI] [PubMed] [Google Scholar]
  364. Wallenda, T. , and Kottke I.. 1998. “Nitrogen Deposition and Ectomycorrhizas.” New Phytologist 139: 169–187. 10.1046/j.1469-8137.1998.00176.x. [DOI] [Google Scholar]
  365. Wang, G. , Li W., Lu X., and Zhao X.. 2011. “Riboflavin Alleviates Cardiac Failure in Type I Diabetic Cardiomyopathy.” Heart International 6: 1–6. 10.4081/hi.2011.e21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  366. Wang, H. X. , Liu W. K., Ng T. B., Ooi V. E. C., and Chang S. T.. 1996. “The Immunomodulatory and Antitumor Activities of Lectins From the Mushroom Tricholoma mongolicum .” Immunopharmacology 31: 205–211. 10.1016/0162-3109(95)00049-6. [DOI] [PubMed] [Google Scholar]
  367. Wang, H. X. , and Ng T. B.. 2001a. “Isolation and Characterization of Velutin, a Novel Low‐Molecular‐Weight Ribosome‐Inactivating Protein From Winter Mushroom (Flammulina velutipes) Fruiting Bodies.” Life Sciences 68: 2151–2158. 10.1016/S0024-3205(01)01023-2. [DOI] [PubMed] [Google Scholar]
  368. Wang, H. X. , and Ng T. B.. 2001b. “Isolation of Pleuturegin, a Novel Ribosome‐Inactivating Protein From Fresh Sclerotia of the Edible Mushroom Pleurotus tuber‐regium .” Biochemical and Biophysical Research Communications 288: 718–721. 10.1006/bbrc.2001.5816. [DOI] [PubMed] [Google Scholar]
  369. Wang, H. X. , Ng T. B., Liu W. K., Ooi V. E. C., and Chang S. T.. 1995. “Isolation and Characterization of Two Distinct Lectins With Antiproliferative Activity From the Cultured Mycelium of the Edible Mushroom Tricholoma mongolicum .” International Journal of Peptide and Protein Research 46: 508–513. 10.1111/j.1399-3011.1995.tb01606.x. [DOI] [PubMed] [Google Scholar]
  370. Wang, H. X. , Ngai H. K., and Ng T. B.. 2003. “A Ubiquitin‐Like Peptide With Ribonuclease Activity Against Various Polyhomoribonucleotides From the Yellow Mushroom Cantharellus cibarius .” Peptides 24: 509–513. 10.1016/s0196-9781(03)00116-5. [DOI] [PubMed] [Google Scholar]
  371. Wang, J. , and Mazza G.. 2002. “Effects of Anthocyanins and Other Phenolic Compounds on the Production of Tumor Necrosis Factor α in LPS/IFN‐γ‐Activated RAW 264.7 Macrophages.” Journal of Agricultural and Food Chemistry 50: 4183–4189. 10.1021/jf011613d. [DOI] [PubMed] [Google Scholar]
  372. Wang, X. M. , Zhang J., Wu L. H., et al. 2014. “A Mini‐Review of Chemical Composition and Nutritional Value of Edible Wild‐Grown Mushroom From China.” Food Chemistry 151: 279–285. 10.1016/j.foodchem.2013.11.062. [DOI] [PubMed] [Google Scholar]
  373. Wani, B. A. , Bodha R. H., and Wani A. H.. 2012. “Nutritional and Medicinal Importance of Pleurotus Mushrooms: An Overview.” Food Review International 28: 313–329. 10.1080/87559129.2011.637267. [DOI] [Google Scholar]
  374. Wasser, S. P. 2002. “Review of Medicinal Mushrooms Advances: Good News From Old Allies.” Herbal Gram 56: 28–33. [Google Scholar]
  375. Wasser, S. P. 2011. “Current Findings, Future Trends, and Unsolved Problems in Studies of Medicinal Mushrooms.” Applied Microbiology and Biotechnology 89: 1323–1332. 10.1007/s00253-010-3067-4. [DOI] [PubMed] [Google Scholar]
  376. Watling, R. 1997. “The Business of Fructification.” Nature 385: 299–300. 10.1038/385299a0.9002510 [DOI] [Google Scholar]
  377. Willis, K. 2018. State of the World's Fungi 2018. Kew: Royal Botanic Gardens. [Google Scholar]
  378. Wills, R. M. , and Lipsey R. G.. 1999. “An Economic Strategy to Develop Non‐Timber Forest Products and Services in British Columbia.” Forest Renewal British Columbia Research Program Grant No. PA97538‐ORE. Accessed October, 2010. http://www.for.gov.bc.ca/hfd/library/frbc1999/FRBC1999MR30.pdf.
  379. Witkowska, A. M. , Zujko M. E., and Mirończuk‐Chodakowska I.. 2011. “Comparative Study of Wild Edible Mushrooms as Sources of Antioxidants.” International Journal of Medicinal Mushrooms 13: 335–341. 10.1615/IntJMedMushr.v13.i4.30. [DOI] [PubMed] [Google Scholar]
  380. Woldegiorgis, A. Z. , Abate D., Haki G., and Ziegler G. R.. 2014. “Antioxidant Property of Edible Mushrooms Collected From Ethiopia.” Food Chemistry 157: 30–36. 10.1016/j.foodchem.2014.02.014. [DOI] [PubMed] [Google Scholar]
  381. Wong, J. H. , Ng T. B., Cheung R. C. F., et al. 2010. “Proteins With Antifungal Properties and Other Medicinal Applications From Plants and Mushrooms.” Applied Microbiology and Biotechnology 87: 1221–1235. 10.1007/s00253-010-2690-4. [DOI] [PubMed] [Google Scholar]
  382. Wong, J. H. , Wang H. X., and Ng T. B.. 2008. “Marmorin, a New Ribosome Inactivating Protein With Antiproliferative and HIV‐1 Reverse Transcriptase Inhibitory Activities From the Mushroom Hypsizigus marmoreus .” Applied Microbiology and Biotechnology 81: 669–674. 10.1007/s00253-008-1639-3. [DOI] [PubMed] [Google Scholar]
  383. Wu, B. , Hussain M., Zhang W., Stadler M., Liu X., and Xiang M.. 2019. “Current Insights Into Fungal Species Diversity and Perspective on Naming the Environmental DNA Sequences of Fungi.” Mycology 10: 127–140. 10.1080/21501203.2019.1614106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  384. Wu, Y. , Teng Y., Li Z., Liao X., and Luo Y.. 2008. “Potential Role of Polycyclic Aromatic Hydrocarbons (PAHs) Oxidation by Fungal Laccase in the Remediation of an Aged Contaminated Soil.” Soil Biology and Biochemistry 40: 789–796. 10.1016/j.soilbio.2007.10.013. [DOI] [Google Scholar]
  385. Wu, Y. , Wang H., and Ng T. B.. 2011. “Purification and Characterization of a Lectin With Antiproliferative Activity Toward Cancer Cells From the Dried Fruit Bodies of Lactarius flavidulus .” Carbohydrate Research 346: 2576–2581. 10.1016/j.carres.2011.09.005. [DOI] [PubMed] [Google Scholar]
  386. Xia, Y. , Shen S., and Verma I. M.. 2014. “NF‐κB, an Active Player in Human Cancers.” Cancer Immunology Research 2: 823–830. 10.1158/2326-6066.CIR-14-0112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  387. Xu, X. , Yan H., Chen J., and Zhang X.. 2011. “Bioactive Proteins From Mushrooms.” Biotechnology Advances 29: 667–674. 10.1016/j.biotechadv.2011.05.003. [DOI] [PubMed] [Google Scholar]
  388. Xue, Z. , Hao J., Yu W., and Kou X.. 2017. “Effects of Processing and Storage Preservation Technologies on Nutritional Quality and Biological Activities of Edible Fungi: A Review.” Journal of Food Process Engineering 40: 1–13. 10.1111/jfpe.12437. [DOI] [Google Scholar]
  389. Yagi, F. , Miyamoto M., Abc T., Minami T., Tadera K., and Goldstein I. J.. 1997. “Purification and Carbohydrate‐Binding Specificity of Agrocybe cylindracea Lectin.” Glycoconjugate Journal 14: 281–288. 10.1023/a:1018558225454. [DOI] [PubMed] [Google Scholar]
  390. Yang, G. , Qu Y., Meng Y., et al. 2019. “A Novel Linear 3‐O‐Methylated Galactan Isolated From Cantharellus cibarius Activates Macrophages.” Carbohydrate Polymers 214: 34–43. 10.1016/j.carbpol.2019.03.002. [DOI] [PubMed] [Google Scholar]
  391. Yau, T. , Dan X., Ng C. C., and Ng T. B.. 2015. “Lectins With Potential for Anti‐Cancer Therapy.” Molecules 20: 3791–3810. 10.3390/molecules20033791. [DOI] [PMC free article] [PubMed] [Google Scholar]
  392. Ye, J. F. , Wang X. D., Wang K., et al. 2020. “A Novel Polysaccharide Isolated From Flammulina velutipes, Characterization, Macrophage Immunomodulatory Activities and Its Impact on Gut Microbiota in Rats.” Journal of Animal Physiology and Animal Nutrition 104: 735–748. 10.3390/10.1111/jpn.13290. [DOI] [PubMed] [Google Scholar]
  393. Zaidman, B. Z. , Yassin M., Mahajna J., and Wasser S. P.. 2005. “Medicinal Mushroom Modulators of Molecular Targets as Cancer Therapeutics.” Applied Microbiology and Biotechnology 67: 453–468. 10.1007/s00253-004-1787-z. [DOI] [PubMed] [Google Scholar]
  394. Zhang, C. X. , Ho S. C., Chen Y. M., Lin F. Y., Fu J. H., and Cheng S. Z.. 2009. “Meat and Egg Consumption and Risk of Breast Cancer Among Chinese Women.” Cancer Causes & Control 20: 1845–1853. 10.1007/s10552-009-9377-0. [DOI] [PubMed] [Google Scholar]
  395. Zhang, L. , Fan C., Liu S., Zang Z., and Jiao L.. 2011. “Chemical Composition and Antitumor Activity of Polysaccharide From Inonotus obliquus .” Journal of Medicinal Plant Research: Planta Medica 5: 1251–1260. [Google Scholar]
  396. Zhang, M. , Cui S. W., Cheung P. C. K., and Wang Q.. 2007. “Antitumor Polysaccharides From Mushrooms: A Review on Their Isolation Process, Structural Characteristics and Antitumor Activity.” Trends in Food Science and Technology 18: 4–19. 10.1016/j.tifs.2006.07.013. [DOI] [Google Scholar]
  397. Zhang, M. , Wang C. Q., Gan M. S., et al. 2022. “Diversity of Cantharellus (Cantharellales, Basidiomycota) in China With Description of Some New Species and New Records.” Journal of Fungi 8: 1–29. 10.3390/jof8050483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  398. Zhao, D. , Ding X., Hou Y., et al. 2018. “Structural Characterization, Immune Regulation and Antioxidant Activity of a New Heteropolysaccharide From Cantharellus cibarius Fr.” International Journal of Molecular Medicine 41: 2744–2754. 10.3892/ijmm.2018.3450. [DOI] [PMC free article] [PubMed] [Google Scholar]
  399. Zhao, S. , Gao Q., Rong C., et al. 2020. “Immunomodulatory Effects of Edible and Medicinal Mushrooms and Their Bioactive Immunoregulatory Products.” Journal of Fungi 6: 1–37. 10.3390/jof6040269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  400. Zhou, R. , Han Y. J., Zhang M. H., Zhang K. R., Ng T. B., and Liu F.. 2017. “Purification and Characterization of a Novel Ubiquitin‐Like Antitumour Protein With Hemagglutinating and Deoxyribonuclease Activities From the Edible Mushroom Ramaria botrytis.” AMB express 7: 1–11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  401. Zuo, X. L. , Chen J. M., Zhou X., Li X. Z., and Mei G. Y.. 2006. “Levels of Selenium, Zinc, Copper, and Antioxidant Enzyme Activity in Patients With Leukemia.” Biological Trace Element Research 114: 41–53. 10.1385/BTER:114:1:41. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The data generated or analyzed that support the findings of this study are available and included in this published article.


Articles from Food Science & Nutrition are provided here courtesy of Wiley

RESOURCES